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KEVIN DALE BALLARD.

Chromatographic and mass spectrometric

analysis of bradykinin related arginyl peptides and other
studies.

(Under the direction of DANIEL R. KNAPP.)

Dimethylpyrimidylornithyl-N-trifluoroethyl-O-TBDMS (DMPO-N-TFE-OTBDMS) polyaminoalcohol derivatives of arginyl peptides were evaluated for their utility in peptide analysis by capillary gas chromatography-mass spectrometry (GC-MS).

These derivatives were hydro-

lytically stable and sufficiently volatile for capillary GC-MS
analysis of low nanomole amounts of peptides as large as RPPGF.
Complete amino acid sequence information was generated under electron impact ionization conditions, including several ions diagnostic
for arginine residues, with molecular weight information imparted by
the [M-15] + and [M-57] + pair of ions characteristic of TBDMS derivatives.

Analysis of the sequential intermediate derivatives by

FAB-MS facilitated optimization of problematic derivatization steps.
As little as 20 picomoles of peptide could be detected by capillary
GC-MS-selected ion monitoring, but problems with the reproducibility
of the diborane reduction reaction limited its utility for quantitative applications.

DMPO-N,O-di-TBDMS polyaminoalcohol derivatives

were found to provide similar structural information, with similar
reproducibility problems at low levels.
A procedure for selectively extracting arginyl peptides using
immobilized phenylboronic acid columns exhibited limited binding

vi

with numerous co-extracted contaminants, and was judged to be
impractical for biological samples.

A reverse phase ion pairing

liquid chromatographic procedure employing alternating ion pairing
reagents successfully isolated 25-35 nanomole amounts of RPP, RPPG
and RPPGF from spiked human urine.

None of these peptides were

detected at this level in unspiked urine.
Further studies focussed on developing sensitive and reliable
means of analyzing RPPGF as the DMPO-N-trifluoroacetyl-O-methyl
ester derivative by direct insertion probe MS, thus avoiding the
problematic diborane reduction reaction.

Under electron impact

ionization conditions, this derivative generated an unusually
intense molecular ion suitable for low and high resolution selected
ion monitoring.

Molecular specificity was obtained by employing

collisionally activated dissociation linked field selected reaction
monitoring mass spectrometry, monitoring the formation of a specific
fragment ion from the molecular ion in the first field free region
of a double focussing mass spectrometer.

With low level samples,

the products at each stage of the derivatization were purified by
reverse or normal phase HPLC.

A 12 nanomole sample of RPPGF isolat-

ed from spiked human urine was successfully analyzed and definitively identified by these methods.
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PART I

CHROMATOGRAPHIC AND MASS SPECTROMETRIC ANALYSIS
OF BRADYKININ RELATED ARGINYL PEPTIDES

CHAPTER I
INTRODUCTION

The potent vasodilator peptide hormone bradykinin has a halflife in blood on the order of 16-20 seconds (1,2); furthermore,
bradykinin is degraded to the extent of 80-95% by a single passage
through the lungs (1-5), and to varying degrees by other tissues
(1,2,6).

Thus, as Kaplan has pointed out (7), "direct determination

of bradykinin as a measure of disease activity is usually unproductive.tI

Considerable insight into the activity of the kallikrein-

kinin system under normal and pathologic conditions could be gained
if specific end-product catabolic fragments of bradykinin were known
and could be quantitated, since such fragments would reflect the
total flux of bradykinin through the system.
Bradykinin is a nonapeptide of sequence Arg-Pro-Pro-Gly-PheSer-Pro-Phe-Arg (single letter amino acid notation (8) RPPGFSPFR),
and is well known to be degraded by two enzymes.

Kininase I (EC

3.4.12.7, carboxypeptidase N) is present in plasma and cleaves the
9

C-terminal arginine residue from bradykinin to yield des-Arg -bradykinin (2,7,9).

Kininase II (EC 3.4.15.1, angiotensin converting

enzyme) is also present in plasma (10), and is highly concentrated
in the lung (2,10) and other tissues (2).

This enzyme, a dipeptidyl

carboxypeptidase, can cleave bradykinin in two steps, first removing
the C-terminal dipeptide FR, and then removing SP, ultimately

2

yielding the pentapeptide RPPGF (2,7,9,10), which is not further
cleaved by kininase II (7).

9

This enzyme can also cleave des-Arg -

bradykinin (produced by kininase I) to yield the pentapeptide RPPGF
plus SPF (7,9).
While the products of the individual enzyme-substrate reactions
are well characterized, the catabolic fragments of bradykinin
generated in vivo are virtually unknown, although a few studies have
provided some valuable information in this area.

In 1968 and 1970,

Ryan and co-workers (3,4) demonstrated that bradykinin is essential-

1y quantitatively degraded by a single pass through the isolated rat
lung, and gives rise to the peptide products PP, RPPG, and FR.

Very

little quantitative information was presented, other than to imply
that PP and RPPG were generated in a 2:1 ratio.
Also in 1970, Keiser and co-workers (11) studied the metabolism
of [14C]-Pro 2 -bradykinin after intravenous infusion in man, and
attempted to identify urinary metabolites.

After 24 hours, urinary

radioactivity accounted for 7-13% of the administered dose, plasma
radioactivity accounted for 5%, with 7S-a5% unaccounted for.
Calculating from the data presented, 5-5.5% of the administered
radioactivity emerged in urine as the dipeptide PP after 2 hours,
and approximately 1.5% emerged as unidentified "basic substances" in
the same time period.

A weak point in this study was the use of the

intravenous infusion, in light of the high efficiency of the lung
for degrading bradykinin.

Since venous blood obligatorily passes

through the lung before reaching other organ systems, the data

3

generated in this study are more indicative of lung metabolism than
whole body metabolism, which might be better represented after
intra-aortic infusion, although this would be difficult to justify
in man.
In 1985, Kaplan and co-workers (7,9) studied the degradation of
bradykinin (500 ng/ml) in citrated plasma using HPLC techniques.
9
After 15 minutes at 37°C, bradykinin, des-Arg -bradykinin, and the
tripeptide SPF were not detectable.

The degradation products

identified by HPLC retention times were free phenylalanine and a
peak suggestive of the tetrapeptide RPPG.

These authors suggested

that a plasma carboxypeptidase is capable of removing C-terminal
9
phenylalanine residues from des-Arg -bradykinin, RPPGF, and SPF.
Data conflicting with the above study were generated by Marceau
and co-workers in 1981 (12). These authors studied the degradation
of bradykinin (100

~g/ml)

in 20% heparinized plasma, and identified

9
des-Arg -bradykinin as the major degradation product by HPLC and
bioassay.

These discrepant findings may be due to either the

incredibly high concentration of bradykinin studied, the use of
diluted plasma, or the use of heparin rather than citrate as an
anticoagulant.
Judging from the above studies, the metabolism of bradykinin is
complex and evidently involves other enzymes in addition to kininases I and II; the carboxypeptidase suggested by Kaplan (7) may be
involved, as well as an aminopeptidase (kininase III) and a dipeptidyl aminopeptidase as suggested by Behal and coworkers (13,14).

4

In none of the above studies were C-terminal or neutral peptides
longer than a dipeptide identified.

The N-terminal tetrapeptide

RPPG was identified in both human plasma and the isolated rat lung
preparation.

The unidentified "basic substances n found by Keiser's

group almost certainly contained the N-terminal RP sequence.

The

pentapeptide RPPGF is suggested as a likely catabolic fragment from
enzymatic studies, since it is generated by two-step sequential
degradation by kininase II, and also by the sequential action of
kininase I followed by kininase II.
Extrapolating from the piecemeal evidence in the studies
described above, a working hypothesis may be formed, stating that
the metabolic products of the peptide hormone bradykinin include
arginine-containing peptide fragments four or more amino acid
residues in length, which retain much of the original amino acid
sequence and thus are highly specific metabolites of bradykinin, and
which when quantitated will serve as useful indicators of the
activity of the kallikrein-kinin system as a whole.

That this

hypothesis has not been thoroughly tested in the past is not surprising since reliable methods for isolating, identifying and
quantitating small arginyl peptides at low levels have not existed.
Due to these considerations, the overall goal of the studies
described here was the elucidation of some of the chemical and
instrumental means which may ultimately be necessary for analyzing
small arginyl peptides with high chemical specificity, high sensitivity and high reliability.

These studies have focussed on the use

5

of the mass spectrometer as the final analytical tool in order to
take advantage of the high sensitivity and specificity afforded by
this instrument.

Gas chromatography-mass spectrometry (GC-MS) of

small peptides has long been recognized for its utility for generating amino acid sequence information (15-29), and its potential value
for quantitating these compounds is beginning to become a reality
(30,31).

Quantitative capillary GC-MS methods using stable isotope

labeled internal standards and selected ion monitoring techniques
generically afford high sensitivity, high specificity, and excellent
precision and accuracy (32,33).

Significant advances in the

quantitation of small peptides by these methods could be brought
about by developing derivatives of peptides which possess good GC
properties, generate intense ions at high mass in the mass spectrometer, and ensure volatilization of the highly polar guanidino group
of arginine residues.
Two general methods have been developed over the past 27 years
for volatilizing peptides for mass spectrometric amino acid sequence
determination, namely the polyaminoalcohol derivatization procedure
(15-23) and the permethylation procedure (25-29).

Both of these

methods have advantages, but in general the polyaminoalcohol derivatives are more volatile, produce more reliable sequence information,
and are more reliably formed (19,34).

With both of these proce-

dures, arginine residues have presented a particular problem because
of the high basicity and polarity of the guanidino group.

The

polyaminoalcohol scheme has traditionally included the conversion of

6

arginine residues to ornithine residues through hydrazinolysis prior
to the chemical derivatization steps.

However, hydrazinolysis can

result in the loss of up to 60% of the original peptide through
peptide bond cleavagej this type of loss would be an obvious impediment to the quantitative analysis of peptides, particularly in terms
of overall sensitivity.

In conjunction with the permethylation

procedure, arginine residues have been successfully volatilized
through derivatization with a-diketone reagents, such as 2,4-pentanedione (acetylacetone), to form substituted or unsubstituted
pyrimidyl-ornithine derivatives without associated peptide bond
cleavage.

This type of derivatization of arginine residues has not

been used in the past with the polyaminoalcohol procedure, although
the two are theoretically compatible.

The diborane reduction step

employed in the conversion of oligopeptides to polyaminoalcohols
does not reduce heterocyclic aromatic ring systems (42), as exemplified by its failure to reduce the side chain groups of tryptophan
and histidine residues (43), and consequently should not reduce
pyrimidyl-ornithine groups.

Thus, the inclusion of this type of

derivatization in the polyaminoalcohol scheme should ensure the
volatilization of arginine-containing peptides without the risk of
peptide bond cleavage during the derivatization reaction.
Another aspect of the polyaminoalcohol scheme which could
potentially be improved is its means of volatilizing hydroxy groups.
The final step in the polyaminoalcohol scheme involves the derivatization of hydroxy functions with the trimethylsilyl (TMS) group.

7

TMS derivatives are highly moisture sensitive and thus inherently
unstable, and, while they give rise to characteristic [M-lSJ+ ions,
these are usually of relatively low intensity.

Studies employing

tertiary-butyldimethylsilyl (TBDMS) derivatives have demonstrated
that TBDMS derivatives are much more hydrolytically stable than TMS
derivatives and, through loss of both a methyl and a tertiary-butyl
group, TBDMS derivatives characteristically give rise to intense
ions corresponding to [M-1S]+ and [M-57]+, which are very useful for
both qualitative and quantitative work (33,44,45).

The reagent

N-methyl-N-(t-butyldimethylsilyl)trifluoroacetamide (MTBSTFA) is
potentially suitable for derivatizing polyaminoalcohols because of
its high reactivity toward hydroxy groups and relatively low reactivity toward secondary amines (46,47).
The relatively new technique of fast atom bombardment mass
spectrometry (FAB-MS) has proven very useful in many recent studies
for ionizing and obtaining mass spectral data on nonvolatile compounds such as underivatized and partially derivatized peptides.
One of the goals of the present studies was to evaluate the utility
of FAB-MS for documenting the success or failure of a series of
sequential derivatization reactions such as those employed with the
polyaminoalcohol scheme.

It was anticipated that by analyzing the

sequential derivatives after each reaction, problematic steps could
be readily identified and remedial measures immediately taken.
Because of the complex nature of most biological samples, it
was anticipated that prepurification of the peptides of interest

8
would be necessary in order to reduce interference with the derivatization reactions and the GC-MS analyses.

Low and high resolution

reverse phase liquid chromatography of peptides using perfluorinated
alkanoic acids as lipophilic ion-pairing reagents are well known and
widely used (48-53).

Additionally, selective extraction of argin-

ine-containing peptides is possible (54,55).

The reversible modifi-

cation of arginine residues of peptides with 1,2-cyclohexanedione
(CHD) to form a vicinal diol derivative (54-56), with subsequent
selective extraction of the modified peptides using immobilized
boronic acid columns (54,55), has been described in the literature
and has been used for the selective extraction of arginine-containing peptides for GC-MS analysis in conjunction with the permethylation method (55).
The guanidino group of arginine residues reacts reversibly with
CHD at pH 8-9 in borate buffers to form a vicinal diol derivative
which is stable under acidic conditions and in borate buffers at pH
8-9.

At pH 7-9 in the absence of borate, the derivative spontane-

ously regenerates CHD and the guanidino group; this reversal process
is quantitative in the presence of nucleophiles such as hydroxylamine (54,56).

Immobilized boronic acid groups interact selectively

with vicinal dial groups at neutral or mildly alkaline pH to form
covalent complexes, a process which can be reversed under acidic
conditions (pH 1-2).

Immobilized boronic acid columns can thus be

used to selectively isolate CHD-modified arginyl peptides, with
elution from the column at low pH, and with subsequent regeneration

9

of the arginine-containing peptide in hydroxylamine buffer at pH 7
(56).

In the published work, large proteins were first modified

with CHD in the presence of borate, then dialyzed against dilute
acetic acid to disrupt the borate complexes and desalt the CHDmodified protein.

CHD-modified peptides were then generated from

the CHD-modified protein by partial hydrolysis, and the CHD-modified
peptides subsequently isolated with immobilized boronic acid
columns.

Since the present studies dealt with small peptides rather

than proteins, the dialysis step employed in the published work was
not feasible, and other methods were therefore necessary to cleave
the diol-borate complexes formed during the initial derivatization
reaction and to desalt the sample.

Toward this end, it was antici-

pated that acidification with a perfluorinated alkanoic acid followed by ion pairing extraction using reverse phase cartridge
columns would be a suitable procedure for hydrolyzing the diolborate complexes and desalting the CHD-modified peptides.
In summary, these studies were undertaken with a view toward
ultimately permitting the testing of the hypothesis that the activity of the kallikrein-kinin system may be estimated through quantitation of putative bradykinin catabolites, a process which has been
limited by the unavailability of sensitive, specific and reliable
means for analyzing small arginyl peptides at low levels.

Toward

this end, the first specific goal was to evaluate the feasibility of
incorporating the formation of volatile dimethylpyrimidylornithyl
derivatives of arginyl peptides into the polyaminoalcohol

10

derivatization scheme for the capillary GC-MS analysis of peptides.
A second related goal was to determine the feasibility of employing
the TBDMS group for volatilizing the hydroxy functions of polyaminoalcohols.

The third primary goal envisioned at the outset of these

studies was to develop efficient and reliable means of isolating
bradykinin related arginyl peptides from complex biological matrices, either by employing reverse phase ion pairing liquid chromatographic procedures alone or in combination with an arginyl peptide
selective extraction procedure which was to be developed.

A fourth

goal was to determine the utility of employing FAB-MS as a means of
verifying sequential isolation procedures and derivatization
reactions.

An overriding goal was to develop mass spectrometric

procedures for analyzing bradykinin related peptides with high
reliability at low levels.

Numerous problems were encountered

during the course of these studies, the nature and solutions to
which will be presented in subsequent chapters.
In order to provide an overview of the detailed material which
follows in subsequent chapters, the results of the present studies
are summarized below.

Initial studies with the simple dipeptide

alanyl-alanine (AA) established the feasibility of employing the
TBDMS group for derivatizing the hydroxy functions of polyaminoalcohols.

Subsequent studies with bradykinin related arginyl

peptides demonstrated that dimethylpyrimidylornithyl-N-trifluoroethyl-O-TBDMS polyaminoalcohol derivatives of these compounds may be

11

formed and that these derivatives are sufficiently volatile for
capillary GC-MS analysis of peptides as large as the pentapeptide
RPPGF.

Under repetitive scanning capillary GC-MS analysis condi-

tions, these derivatives generate complete amino acid sequence
information in a fashion directly analogous to that of the well
known N-trifluoroethyl-O-TMS polyaminoalcohols (17), with the
additional molecular weight information provided by the easily
recognized pair of ions corresponding to [M-lS]+ and [M-57]+ which
is characteristic of TBDMS derivatives.

These derivatives also

generate several ions diagnostic for arginine residues, and were
found to be hydrolytically stable and useful for structural analysis
of arginyl peptides at nanomole levels.

During sensitivity studies

with low level samples, as little as 20 pmoles of peptide could be
detected by capillary GC-MS-SIM with good signal to noise ratio.
Unfortunately, reproducibility problems with the derivatization
chemistry, particularly the diborane reduction reaction, limited the
utility of these derivatives for quantitative analysis of low level
samples of arginyl peptides.

The use of FAB-MS was particularly

beneficial during these studies because it enabled the analysis of
the sequential intermediate derivatives, and thus permitted ready
identification of problematic derivatization steps.

Some of the

reaction conditions advocated in the most recently published version
of the polyaminoalcohol scheme were not found to be optimal for the
peptides employed in these studies.

FAB-MS facilitated the identi-

fication of these problems so that corrective action could be taken.
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Dimethylpyrimidylornithyl-N,O-di-TBDMS polyaminoalcohol derivatives of arginyl peptides were briefly explored as a possible
solution to some of the reproducibility problems encountered with
the N-trifluoroethyl derivatives.

The di-TBDMS derivatives were

found to be suitable for capillary GC-MS analysis and to provide
structural information similar to their N-trifluoroethyl counterparts.

However, poor reproducibility was encountered with both the

diborane reduction and the silylation reactions with these derivatives even at high nanomole levels.
A general procedure was developed for the selective extraction
of arginyl peptides from aqueous matrices employing immobilized
phenylboronic acid columns.

This procedure was found to

succ~ssful

ly isolate standard arginyl peptides from aqueous buffers, and was
demonstrated to be compatible with the derivatization procedures for
capillary GC-MS analysis of these peptides.

However, high perfor-

mance liquid chromatographic (HPLC) analysis of the extracts showed
that numerous contaminating species were present in the extracts,
and that the phenylboronic acid columns employed exhibit a very
limited binding capacity.

This procedure was therefore judged to be

impractical for the isolation of arginyl peptides from biological
matrices.
A complex but higttly efficient procedure was developed for the
isolation of the bradykinin related peptides RPP, RPPG and RPPGF
from complex biological matrices, particularly urine.

This proce-

dure was based on a combination of low and high resolution reverse
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phase ion pairing liquid chromatography, with alternating ion
pairing reagents.

Low and high resolution FAB-MS demonstrated the

successful isolation of 25-35 nmole amounts of these peptides from a
spiked 20 ml human urine sample.
Further studies focussed on developing sensitive and reliable
means of analyzing the pentapeptide RPPGF, which was consistently
the most problematic of the peptides studied.

These experiments

employed the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl
ester derivative, which was sufficiently volatile for direct insertion probe mass spectrometric analysis.

The use of this derivative

avoided the problematic diborane reduction reaction.

Under electron

impact ionization conditions, the molecular ion of this derivative
was of unusually high intensity and was suitable for direct insertion probe selected ion monitoring mass spectrometric analysis under
both low and high resolution conditions.

Further molecular speci-

ficity was obtained by employing direct insertion probe collisionally activated dissociation linked field selected reaction monitoring mass spectrometry, monitoring the formation of a specific
fragment ion from the molecular ion in the first field free region
of a double focussing mass spectrometer.

Success with low level

samples was obtained through HPLC isolation of the sequential
derivatives, with the final derivative isolated by normal phase
HPLC.

A sample of RPPGF isolated from spiked human urine was

successfully analyzed and definitively identified by these methods.

CHAPTER II
METHODS

A.

Reagents.
Acetonitrile, chloroform, methylene chloride and methanol were

glass distilled UV grade (Burdick and Jackson Laboratories, Inc.,
Muskegan, MI).

Water used for HPLC was analytical grade deionized,

while water used for derivatization reactions was distilled in glass
with reflux under argon and stored under argon at 4 °C.

Trifluoro-

acetic acid (TFA, Fisher Scientific Co., Pittsburg, PA) was redistilled with reflux under nitrogen; heptafluorobutyric acid (HFBA,
Aldrich Chemical Co., Milwaukee, WI) was used without further
purification.

Acetylacetone (Aldrich Gold Label), triethylamine

(Fisher), pyridine (Fisher) and methyl trifluoroacetate (Alfa
Products, Danvers, MA) were all redistilled in glass with reflux
under argon.

Acetylacetone, triethylamine and pyridine were stored

under argon at -80 °C and warmed to room temperature just prior to
use.

Tetrahydrofuran was UV grade (Burdick and Jackson) stored over

SA molecular sieves at room temperature (57).

N-methyl-N-t-butyldi-

methylsilyltrifluoroacetamide (MTBSTFA, Regis 'Chemical Co., Morton
Grove, IL) and N-methyl-bis(trifluoroacetamide) (MBTFA, Pierce
Chemical Co., Rockford, 1L) were stored at 4 °C and warmed to room
temperature prior to use.

Methanolic Hel was freshly generated

prior to use by slowly adding a stoichiometric amount of acetyl
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chloride (Fisher) to methanol under argon at -10°C.

Ethereal

diazomethane was freshly generated prior to use from N-methyl-Nnitroso-N1-nitroguanidine (Aldrich), 6N sodium hydroxide and diethyl
ether (Fisher) using the apparatus and conditions described by Fales
and co-workers (58).

One molar diborane/tetrahydrofuran solution

stabilized with 0.005 M sodium borohydride (Aldrich) was stored at 4
°C under nitrogen.

Cyclohexanedione (Aldrich), N-ethylmorpholine

(Aldrich) and glycerol (Fisher) were reagent grade.
The peptides Ala-Ala (AA, Sigma Chemical Co., St. Louis, MO),
Arg-Phe (RF, Vega Biochemicals, Tucson, AZ), Arg-Pro-Pro (RPP, Serva
Fine Biochemicals Inc., Westbury, NY), Arg-Pro-Pro-Gly (RPPG, Bachem
Inc., Torrance, CA) and Arg-Pro-Pro-Gly-Phe (RPPGF, Serva) were
stored dessicated at -20°C.

These peptides were all of high purity

with the exception of RPPG, the purity of which was estimated at 30%
based upon HPLC and FAB-MS analysis.

The amino acid L-(+)-arginine

(Aldrich) was stored at room temperature.
All other chemicals were reagent grade from commercial sources
and were used without further purification.

B.

Glassware.
Derivatization reactions were carried out in 1 or 2 ml Reacti-

lials (Pierce) with Teflon lined caps.

All glassware which came in

contact with analytical samples was silanized by immersion in a 2%
(v/v) solution of dimethyldichlorosilane in toluene for 20 minutes,
followed by thorough rinsing with absolute methanol (59 a).
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c.

Evaporation techniques.
Excess derivatization reagents and solvents were removed either

by evaporation under a stream of nitrogen or argon in a room temperature water bath, or by evaporation under vacuum with centrifugation
on a Speed-Vac Concentrator (Savant Instruments, Inc., Hicksville,

NY).

The Speed-Vac was equipped with a cold trap and a Precision

Scientific Model 75 vacuum pump (Precision Scientific Co., Chicago,

IL).

D.

High Performance Liquid Chromatography.
High performance liquid chromatographic (HPLC) analyses were

performed using a Waters Associates (Milford, MA) gradient elution

HPLC system consisting of two Mode! 510 HPLC pumps a Model 680
automated gradient controller, a Model U6K injector, and a Model 441
absorbance detector.

Chromatograms were recorded with a Fisher

Recorda!l Series 5000 recorder.

Reverse phase HPLC analyses were

performed using a Vydac Protein and Peptides C
5
1S

X 4.6

mm i.d.,

a guard column.

~m

column (25 cm

The Sep/a/ra/tions Group, Hesperia, CA) equipped with
Normal phase HPLC analyses were performed using an

Econosphere Silica 5

~m

column (25 cm X 4.6 mm i.d., Alltech Associ-

ates, Inc., Deerfield, IL).
Two types of reverse phase analyses were performed during the
course of these studies, depending upon whether trifluoroacetic acid
(TFA) or heptafluorobutyric acid (HFBA) was used as the ion pairing
reagent.

Water and acetonitrile were the base solvents used in both
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systems, with the ion pairing reagent at a concentration of 0.1% (by
volume) in each solvent.

For the TFA system, the column was equili-

brated with 0.1% TFA/water.

At the time of injection, a linear

gradient was initiated with 0.1% TFA/acetonitrile at a rate of 1%
acetonitrile per minute.

Similarly, for the HFBA system, the column

was equilibrated with 0.1% HFBA/water, and a linear gradient with
0.1% HFBA/acetonitrile at a rate of 2% acetonitrile per minute was
initiated at the time of injection.

For both systems, the flow rate

was 1.5 ml/min throughout, with UV detection at 214 nm and a typical
sensitivity setting of 0.5 absorbance units for a full scale deflection.
Normal phase HPLC analyses were performed by equilibrating the
column with chloroform, then at the time of injection initiating a
linear methanol gradient to a final methanol concentration of 10i.
over a twenty minute time period.

Detection was with UV absorbance

at 254 nm, with a typical sensitivity setting of 0.05 absorbance
units for a full scale pen deflection.

E.

Mass Spectrometry and Gas ChromatographY-Mass Spectrometry.
All mass spectrometric analyses performed during the course of

these studies employed a Finnigan MAT 212 double focussing mass
spectrometer.

This instrument is of reverse Nier-Johnson geometry

(the magnetic sector preceeds the electric sector), has a nominal
accelerating voltage of 3 kV, and has a routine high resolution
capability of 15-20,000.

The mass spectrometer was interfaced to a

18

Finnigan Spectrosystem S3200 data system equipped with selected ion
monitoring hardware for data acquisition during repetitive scanning
and selected ion monitoring experiments.

When appropriate, a Bell

an Howell Model 525150 oscillographic recorder (Bell and Howell,
Pasadena, CA) was used for the recording of mass spectral data.
For fast atom bombardment mass spectrometric (FAB-MS) analyses,
an Ion Tech FABI1NF saddle field fast atom gun (Ion Tech Ltd.,
Middlesex, England) powered by an Ion Tech BSO power supply was
adapted to the MAT 212.

Xenon gas was introduced into the FAB gun

through a Granville-Phillips Variable Leak valve (Series 203,
Granville-Phillips Co., Boulder, CO).

The probe used for FAB-MS was

fabricated in these laboratories, employing a 316 stainless steel
brush finished probe tip (angle of incidence 60°) and an insulator
fabricated from Kel-F.

For a typical analysis, the probe tip was

first coated with a thin layer of glycerol.

Then, a small amount of

the solid or oily analytical sample was removed from the sample vial
using a clean stainless steel wand, and was mixed with the glycerol
directly on the probe tip.

The FAB probe was then introduced into

the ion source, the FAB gun was turned on with xenon accelerated to

6-8 kV, and several scans were recorded over the 15-1000 atomic mass
unit (amu) range at a scan rate of 8 sec/decade.

These techniques

generally produced excellent results with very little sample consumption.

Ion source potentials were optimized while monitoring the

m/z 277 ion of glycerol, and a mixture of poly(ethyleneglycol)s of
average molecular weight 200, 400 and 600 (Aldrich) was used for
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routinely calibrating the mass spectrometer under FAB conditions.
The typical ion source pressure was 5 x 10

-6

torr, and the ion

source was operated at room temperature.
A Varian 3700 gas chromatograph (Varian Associates, Inc., Palo
Alto, CA) was interfaced to the MAT 212 for capillary gas chromatography-mass spectrometry (GC-MS) analyses.
silica DB-1 and DB-5 (0.25 rom i.d., 0.25

Columns used were fused

~m

film thickness, J&W

Scientific, Inc., Rancho Cordova, CA) columns 4-30 m in length, with
the outlet end introduced directly into the ion source of the mass

spectrometer through a heated transfer line (290-320 °C).

The gas

chromatograph was modified to incorporate an on-column injector
fabricated in these laboratories employing glass inserts purchased
from J&W Scientific.

For a typical analysis, 3-5

~l

of sample were

slowly injected on-column in the cooled zone with the GC oven
temperature 10-15 °C above the nominal boiling point of the highestboiling solvent component in the sample.

The on-column injector was

then lowered and. after solvent clearance. the GC oven temperature
was programmed at a rate of 5-10 °C/min to a maximum of 325°C.
Data collection was initiated at the moment of temperature program
initiation.

High purity helium (>99.95 %) was used as the carrier

gas, with the capillary head pressure adjusted to give an average

linear velocity of 45-55 em/sec at the upper GC oven temperatures
(60).

The ion source of the mass spectrometer was maintained at a

temperature of 250°C.

The mass spectrometer was operated in

electron impact mode. with an electron energy of 70 eV and 1 rnA
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electron emission.

For all GC-MS analyses, the ion source poten-

tials were optimized while monitoring the m/z 207 GC bleed ion with
the GC oven at or near the temperature of elution of the samples.
Repetitive scanning GC-MS analyses were performed with the mass
spectrometer operated at a resolution of 1,900-2,300 (50% peak
height definition), scanning the 70-1000 amu range at a rate of
3 sec/decade, with an interscan time of 600 msec.

For selected ion

monitoring experiments, the mass spectrometer was set at a resolution af 1,000-1,200 with a flat topped peak shape.

The magnet was

operated in current regulation mode for field strength stability,
and was manually focussed to the center of the ion of interest using
a standard sample as reference material.

The secondary electron

multiplier was operated at 2,200 V for high level samples and at
2,800 V for low level samples.

Selected ion monitoring data were

collected using the SS200 data system at a rate of 5-10 intensity
readings per second (each intensity reading was the average of 16
individual samples).

Perfluorokerosine (peR Inc., Gainesville, FL)

was used to calibrate the mass spectrometer under electron impact
conditions.
Direct insertion probe mass spectrometric (DIP-MS) analyses
were performed with the FAB gun removed from the MAT 212 and replaced with a lock valve to permit the introduction of the heated
DIP.

For all DIP-MS experiments, 2-6

~l

of dissolved sample were

introduced into a 1.9 mm x 10 mm glass DIP sample vial.

The DIP

vial was placed into a 1 ml Reactivial, and solvents were removed

21
under vacuum with centrifugation on the Speed-Vac.

This process was

repeated if necessary to accumulate sufficient material in the DIP
vial for analysis.

The vial was then immediately inserted into the

probe tip and introduced into the ion source of the mass spectrometer at room temperature.

After instrumental stabilization, data

collection and probe heating were initiated.

The mass spectrometer

was operated in electron impact mode for all DIP-MS experiments,
with an electron energy of 70 eV, an electron emission of 1 mA, and
with the ion source temperature maintained at 250°C.
Repetitive scanning data were obtained with the instrument set
at a resolution of 1,900-2,300, scanning over the 100-1000 amu range
at a scan rate of 3 sec/decade.

The probe was heated at a rate of

0.6-1.3 °C/sec during these experiments.
Low resolution direct insertion probe selected ion monitoring
analyses were performed with the mass spectrometer set at a resolution of 1,000-1200 with a flat topped peak shape.

The magnet,

operated in current regulation mode, was focussed manually to the
center of the ion of interest using a standard sample as reference
material.

The analytical sample was run immediately thereafter.

The probe was heated at a rate of 1.3-2 °C/sec during these
experiments.
For high resolution direct insertion probe selected ion monitoring experiments, the mass spectrometer was tuned to a resolution
of 14-15,000.

The magnet, operated in current regulation mode, was

manually coarsely focussed to the region of the ion of interest
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using a magnetic calibration table generated by the S5200 data
system (CALIB routine) accurate to within 0.2 atomic mass units.
Perfluorokerosene was introduced into the mass spectrometer as a
reference sample, and the accelerating voltage was electrically
jumped (MACQ routine using MISLRS microcode) to a perfluorokerosine
ion slightly higher in mass than the ion of interest using a highly
accurate electrical calibration table generated by the SS200 data
system (ECAL routine).

The magnet was then finely adjusted manually

to focus the reference mass.

Perfluorokerosine introduction was

then stopped and the data system was set for selected ion monitoring
of the ion of interest.

The analytical sample was run immediately

thereafter in order to avoid magnetic field strength drift, typical1y with a probe heating rate of 2°C/sec.
Direct insertion probe collisionally activated dissociation
selected reaction monitoring mass spectrometry (DIP-CAD-SRM-MS)
experiments were performed with the mass spectrometer set at a
resolution of 1,000-1200.
activation in these

Xenon gas was used for collisional

experiments~

and was introduced into the region

of the ion source and the first field free region of the mass spectrometer through a Granville-Phillips Variable Leak valve and a 2 m
segment of 0.25 mm i.d. fused silica capillary tubing.

Good results

were obtained with the xenon flow adjusted to give an ion source
pressure of 6-8 x 10

-6

torr.

For these experiments, the linked

field unit of the MAT 212 was operated in B/E mode to maintain a
cons~ant

relationship between the field strengths of the magnetic
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and electric sectors.

The magnet and the linked field unit were

adjusted to focus the precursor ion of interest using a standard
sample as reference material (this process determines the constant

B/E to be used by the linked field unit).

The linked field unit was

then switched to "measure" to maintain the ratio B/E constant, and
the magnet was refocused to the center of the fragment ion of
interest using the standard sample as a reference.

The analytical

sample was. run immediately thereafter, with the data system operated
in selected ion monitoring mode, and with the DIP heated at a rate
of 2-3 °C/sec.

F.

Condensation of arginine residues with 2,4-pentanedione
(acetylacetone) .
For most experiments with arginyl peptides, the procedure

described by Morris and co-workers (38) was used with little modification.

To the dry peptide sample (20 pmoles to 100 nmoles) were

added 50

~l

of water, 100

triethylamine.
centrifuged.
added.

~l

of absolute ethanol and 50

~l

of

The sample-was capped under argon, vortexed and
Under a flow of argon, 100

~l

of acetylacetone were

The sample was again capped under argon, vortexed and heated

at 100°C for four hours with occasional vortexing during heating.

The sample was then allowed to cool and placed on the Speed-Vac to
reduce the volume to less than 5
and glacial acetic acid (25

~l)

~l

of yellow oil.

Water (250

were added, and the sample was

vortexed and then heated at 100 °C for twelve minutes with

~l)
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occasional vortexing during heating. The sample was allowed to cool
and extracted three times with 500-700

~l

of diethyl ether, with

centrifugation to ensure complete separation of layers.

The organic

layers were discarded, and the aqueous sample was placed on the
Speed-Vac until the volume was reduced to dryness.

The sample was

suitable for FAB-MS analysis at this stage.

G.

Methylation of carboxylic acid groups with diazomethane.
Methanol (250

~l)

was added to the dry sample, which was then

capped under nitrogen, vortexed, sonicated 15 min and cooled to

o °C.
500

Freshly generated ethereal diazomethane (approximately

~l)

was added, and the sample was vortexed and immediately

placed on the Speed-Vac to remove excess diazomethane and solvents.
The dry sample was suitable for FAB-MS analysis.

H.

Methylation of carboxylic acid groups with 3 M methanolic HCI.

To the dry sample were added approximately 500

~l

of freshly

generated anhydrous 3 M methanolic He!; the sample was then sonicated for one hour with occasional vortexing.

Methanol and excess

HCl were removed by evaporation under a stream of nitrogen.

Seven

drops of methanol were added, and the sample was vortexed, centrifuged and evaporated to dryness on the Speed-Vac, after which the
sample was suitable for FAB-MS analysis.
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I.

Trifluoroacetylation of amino groups with methyl
trifluoroacetate.
Peptides were trifluoroacetylated with methyl trifluoroacetate

essentially according to the published procedure (17).
sample were added 250
250

~l

~l

of methanol, 20

of methyl trifluoroacetate.

~l

To the dry

of triethylamine and

The sample was capped under

nitrogen, vortexed and allowed to stand overnight at room temperature in the dark.

The sample was then placed on the Speed-Vac to

remove excess derivatization reagents and solvents.

At this stage

the sample was suitable for FAB-MS analysis.

J.

Trifluoroacetylation of amino groups with N-methyl-bis(trifluoroacetamide) (MBTFA).
Anhydrous tetrahydrofuran (200

acetamide) (MBTFA, 50

~l)

~l)

and N-methyl-bis(trifluoro-

were added to the dry sample.

The sample

was then capped under nitrogen or argon, vortexed and heated at
80°C for 30-50 minutes.

The sample was then sonicated for 30 min-

utes to help ensure complete dissolution, and heated 30 more minutes
at 80 °C, with occasional vortexing during both heating steps.

The

sample was then allowed to cool and evaporated to dryness on the
Speed-Vac, after which the sample could be analyzed by FAB-MS.

K.

Reduction of amide and ester groups with diborane.
Samples were reduced with diborane using the published proce-

dure (17) essentially without modification.

The dry sample was
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capped under nitrogen and cooled to 0 °C in an ice bath.
diborane-tetrahydrofuran solution (200

~l)

One molar

was added, and the sample

was vortexed and heated at 90°C for 30 minutes, with occasional
vortexing during heating.

The sample was then cooled to 0 °C in an

ice bath, and excess diborane was destroyed by the careful dropwise
addition of methanol, during which operation vigorous bubbling
occurred.

After bubbling had ceased, solvents and trimethoxyborane

were removed by evaporation on the Speed-Vac.

Boroamine complexes

were then decomposed by the addition of 1 M methanolic Hel (approximately 500

~1),

with heating at 90°C for 30 minutes.

The sample

was allowed to cool, evaporated to dryness on the Speed-Vac, and the
boroamine decomposition process was repeated.
In order to convert the resulting polyaminoalcohol hydrochloride salts to the free polyaminoalcohols, the dry sample was dissolved in 200

~l

of 25% (w/v) aqueous potassium carbonate and

extracted three times with 200

~l

of methylene chloride.

The sample

was centrifuged to ensure complete separation of layers, and the
organic layers (lower) were combined.
added 200

~l

To the aqueous layer were

of 120% (w/v) aqueous potassium carbonate plus

50-100 mg solid potassium carbonate.
three times with 400

~l

The sample was then extracted

of methylene chloride, and the organic

layers (upper) were combined with those from the first extraction
process.

The combined extract was then centrifuged to separate out

any residual aqueous phase, and transferred to another clean sample
-.

vial, with care taken to avoid transferring any water droplets.

The
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extract was then evaporated to dryness on the Speed-Vac.

At this

stage the sample was suitable for FAB-MS analysis.

L.

Silylation of hydroxy groups with N-methyl-N-t-butyldimethylsilyltrifluoroacetamide (MTBSTFA).
To the dry sample were added 65

MTBSTFA.

~l

of pyridine and 35

~l

of

The sample was then vortexed and heated at 80 °C for one

hour, with occasional vortexing during heating.

The sample was

allowed to cool and evaporated to dryness on the Speed-Vac.
sample could be analyzed by FAB-MS at this stage.

The dry

The sample was

then redissolved under nitrogen with vortexing and sonication in an
appropriate volume of pyridine (typically 10-100

~l).

The sample

was then ready for GC-MS analysis.

M.

Feasibility of N-trifluoroethyl-O-TBDMS polyaminoalcohol
derivatives.
In order to explore the feasibility of forming and analyzing

N-trifluoroethyl-O-TBDMS polyaminoalcohol derivatives of peptides, a
series of samples of the simple dipeptide AA (0.4 - 1.2 mg) were
methylated with ethereal diazomethane, trifluoroacetylated with
methyl trifluoroacetate, reduced with diborane and silylated with
MTBSTFA.

Reactions were carried out as described above with the

exception of the methylation reaction, which was performed in the
follo~ing

manner.

The sample was first converted to the hydrochlo-

ride salt form by adding 500

~l

of 1 N methanolic Hel to the dry
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peptide, vortexing and immediately evaporating the sample to dryness
on the Speed-Vac.

The sample was then dissolved in 250

~l

of

methanol, and ethereal diazomethane was added until the yellow color
of diazomethane persisted.

The sample was then sonicated for

30 minutes and evaporated to dryness on the Speed-Vac.
Samples were anaylzed by FAB-MS after methylation, DIP-MS after
trifluoroacetylation, FAB-MS after reduction, and by GC-MS after
silylation.

N.

Compatibility of DMPO derivatives of arginyl residues with
diborane reduction.
The compatibility of the dimethylpyrimidyl ring system with the

diborane reduction reaction was tested by converting arginine to
dimethylpyrimidylornithine aminoalcohol at a semi-synthetic level in
the following manner.

Arginine (5 mg) was converted to dimethyl-

pyrimidylornithine through derivatization with acetylacetone as described in section F above and analyzed by by FAB-MS.

The sample

was then sonicated in a mixture of methanol and ethereal diazomethane until all solid dissolved and the yellow color of diazomethane

persisted.

Solvents and excess diazomethane were removed by evapo-

ration on the Speed-Vac, and the sample was analyzed by FAB-MS.
sample was then reduced with 800

~l

of 1 M diborane-tetrahydrofuran

solution as described in section K above.
analyzed by FAB-MS.

The

The isolated product was
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O.

Trifluoroacetylation: methyl trifluoroacetate versus MBTFA.
The efficiency of the trifluoroacetylation of the amino groups

of arginyl peptides with methyl trifluoroacetate was tested using a

1.2

~mole

sample of the dipeptide RF.

The peptide was converted to

the DMPO derivative by condensation with acetylacetone, then methylated with ethereal diazomethane.

The resulting methyl ester was

treated with methyl trifluoroacetate as described in section I
above.

After evaporation on the Speed-Vac, the sample was analyzed

by FAB-MS.
Further evaluation of the trifluoroacetylation of amino groups
with methyl trifluoroacetate was accomplished by carrying a series
of samples of RF (0.6 - 1.6

~moles)

through the entire derivatiza-

tion process (condensation with acetylacetone, methylation, trifluoroacetylation with methyl trifluoroacetate, reduction and
silylation), varying the trifluoroacetylation reaction time from
twelve to thirty-six hours.

The fully derivatized samples were

analyzed by capillary GC-MS-SIM, monitoring m/z 408.
The feasibility of employing METFA for trifluoroacetylating the
amino groups of arginyl peptides was tested using a 300 nmole sample
of RF.

The dipeptide was converted to the DMPO derivative with

acetylacetone and methylated with 3 M methanolic Hel.

The sample

was then treated with MBTFA using the procedure described in section
J above.

The dry sample was analyzed by FAB-MS.
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P.

Verification of sequential derivatization reactions by FAB-MS
and capillary GC-MS.
A series of samples (170 - 600 nmoles) of RE, RPP, RPPG, and

RPPGF were carried through the entire derivatization process to
convert them to the corresponding DMPO-N-TFE-O-TBDMS polyaminoalcohoI derivatives.

Using the general procedures described above, each

sample was condensed with acetylacetone, methylated with ethereal
diazomethane, trifluoroacetylated with with MBTFA, reduced with
diborane and silylated with MTBSTFA.

At the end of each derivatiz-

ation step, each sample was analyzed BY FAB-MS to determine the
success or failure of the sequential reactions.

The fully deriva-

tized samples were analyzed by both FAB-MS and capillary GC-MS.

Q.

Methylation - ethereal diazomethane versus methanolic HCl.
In order to evaluate the relative utility of ethereal diazo-

methane and methanolic Hel as methylating reagents within the
overall derivatization process, the two reagents were compared in
parallel experiments.

Two mixtures, each containing RPP

(27 nmoles), RPPG (12 nmoles), and RPPGF (17 nmoles) were carried
through the entire derivatization process.

One mixture was methyl-

ated with ethereal diazomethane, the other with 3 M methanolic Hel;
otherwise the samples were treated identically (both were trifluoroacetylated with MBTFA).

The fully derivatized samples were analyzed

by capillary GC-MS-SIM, monitoring the m/z 358 ion common to the
three derivatized peptides.

31
R.

Sensitivity studies.
Overall sensitivity limits for the analysis of arginyl peptides

as DMPO-N-TFE-Q-TBDMS polyaminoalcohol derivatives by capillary
GC-MS-SIM were evaluated using a series of sample mixtures containing from 20 pmoles to 27 nmoles of each of the peptides RPP, RPPG
and RPPGF.

The mixtures were treated with acetylacetone, 3 M

methanolic HCI, MBTFA, diborane and MTBSTFA as described above.

The

mixtures were analyzed by capillary GC-MS-SIM, monitoring the
m/z 358 ion common to the three derivatized peptides.

s.

DMPO-N,O-di-TBDMS polyaminoalcohol derivatives of arginyl
peptides.
A series of samples (50 - 250 nmoles) of the peptides RF, RPP

and RPPG were condensed with acetylacetone and reduced with diborane
as described above (no methylation or trifluoroacetylation).
dry samples were added 50

~l

of acetonitrile and 25

~l

To the

of MTBSTFA.

The samples were capped under nitrogen and heated at 60°C for
fifteen to thirty minutes.

Samples of RF were analyzed by FAB-MS

after each sequential reaction.

All samples were analyzed by

cap·il1ary GC-MS.

T.

Arginyl peptide selective extraction procedure.
The following general procedure was developed for the selective

extraction of arginyl peptides from aqueous matrices.
cartridge columns were C

Reverse phase

1S Sep-Paks (Waters Associates), which were
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charged with 10 ml of 80% acetonitrile/water/O.l% HFBA, and washed
and equilibrated with 10 ml of 0.1% HFBA/water.

Immobilized phenyl-

boronic acid (PBA) columns were Bond Elut PBA columns (Analytichem
International, Harbor City, CA), which were washed with 5 ml of
aqueous 1% N-ethylmorpholine buffer (NEM, pH 8.0 (55»

followed by

5 ml of 0.1% HFBA/water, then equilibrated with 5 ml of 1% NEM
buffer.
The sample was first desalted by rendering it 1 to 1.5% by
volume in HFBA (enough to acidify the sample to pH 1-2, and at least
1%), loading it onto a charged and washed CIS Sep-Pak, washing with
10 ml of 0.1% HFBA/water to effect desalting, and eluting with
2-3 ml of 80% acetonitrile/water/D.l% HFBA.

The sample was then

evaporated to dryness on the Speed-Vac and redissolved with sonication in 1 ml of nitrogen saturated 0.15 M 1,2-cyclohexanedione in
aqueous 0.25 M sodium borate buffer (pH 8.7) (55).

The reaction

mixture was heated at 40°C for three hours to form the borate-complexed dihydroxycyclohexyl derivatives of arginyl peptides.

The

sample was then allowed to cool and acidified to pH 1-2 with HFBA to
hydrolyze the borate complexes.

After 30-45 minutes at room temper-

ature, the sample was desalted with a CIa Sep-Pak as described above
and evaporated to dryness on the Speed-Vac.

The sample was then

redissolved with sonication in 2-4 ml of 1% NEM buffer and loaded
onto a PBA column.

The column was washed with 5 ml of 1% NEM

buffer, then eluted directly onto a CIS Sep-Pak with 5 ml of
1% HFBA/water.

The Sep-Pak was washed with 10 ml of 0.1% HFBA/water
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and the sample was eluted with 2-3 ml of 80% acetonitrile/water/O.l% HFBA.

The eluate was evaporated to dryness on the Speed-

Vac.
Samples of RF and RPPG (250 nmoles) were extracted from phosphate buffered saline (PBS) using these methods and analyzed by
FAB-MS.

An RF sample so extracted was derivatized to form the

DMPO-N,O-di-TBDMS polyaminoalcohol and analyzed by capillary
GC-MS-SIM, monitoring m/z 176.
The arginyl peptide selective extraction procedure was further
evaluated using a sample containing 175 - 250 nmoles of each of the
peptides RPP, RPPG and RPPGF in PBS, and a blank sample of PBS.
These two samples were carried through the extraction procedure, and
the extracts were redissolved in 0.1% TFA/water and analyzed by
reverse phase ion pairing HPLC using the acetonitrile/water/TFA
system described above.

u.

Reverse phase ion pairing chromatographic isolation of RPP,
RPPG and RPPGF.
The following procedure was developed for the isolation of RPP,

RPPG and RPPGF from complex biological matrices.

The Sep-Pak

extraction steps were perfromed using two C Sep-Paks connected in
1S
series through a short segment of silanized glass tubing to double
the total binding capacity.

The double Sep-Paks were charged with

10 ml of 80% acetonitrile/water/O.l% HFBA and washed with 10 ml of
0.1% HFBA/water.
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The sample was rendered 1% by volume in HFBA, and the pH was
checked to ensure that the buffer capacity of the sample was overcome by the HFBA.

The sample was then loaded onto a charged and

washed double CIS Sep-Pak, washed with 10 ml of 0.1% HFBA/water, and
eluted with 35 ml of water saturated with diethyl ether containing
4

1% HFBA.

After the ether was removed by rotary evaporation, the

eluate was again loaded onto a double CIS Sep-Pak and washed with 10
ml of 0.1% HFBA/water.

The double cartridge column was then eluted

with 10 ml of 10% acetonitrile/water/O.l% HFBA, to yield fraction Al
(the RPP and RPPG fraction).

The double column was washed with

10 ml of 18% acetonitrile/water/O.l% HFBA, and finally eluted with
10 rnl of,25% acetonitrile/water/0.1% HFBA to yield fraction Bl (the
RPPGF fraction).
Fractions Al and Bl were evaporated under a stream of nitrogen
to remove acetonitrile, lyophilized, redissolved with sonication in
2 ml of 0.1% TFA/water and filtered through Acrodisc 13 CR (0.45
Gelman Sciences Inc., Ann Arbor, MI) filters.

~m,

Each fraction was

then chromatographed by reverse phase ion pairing HPLC using the
acetonitrile/water/TFA system.

The region of the chromatogram

corresponding to RPP and RPPG was collected from fraction Al to
yield fraction A2, and the region corresponding to RPPGF was collected from fraction Bl to yield fraction B2.

On a day-to-day

basis, the appropriate regions of the chromatograms were located by
co-injecting a small amount of the analytical samples with a known
amount of the standard peptides.

For sample collections, 200-650

~l

35

were injected per run.

The individual collections from multiple

chromatograms were pooled as fractions A2 and B2.
Fractions A2 and B2 were evaporated under a stream of nitrogen
to remove acetonitrile, lyophilized, redissolved with sonication in
10 ml of 0.1% HFBA/water, and filtered through Acrodisc 13 CR
(0.45

~m,

Gelman) filters.

The fractions were then rechromato-

graphed by reverse phase ion pairing HPLC using the acetonitrile/water/HFBA system, with 0.5 to 1.8 ml injected for each run.

The

region of the chromatogram corresponding to RPP and RPPG was collected from fraction A2 to yield fraction A3, and the region corresponding to RPPGF was collected from fraction B2 to yield fraction
B3.

Again, collections from multiple chromatograms were pooled as

fractions A3 and B3.

Aliquots of these fractions were evaporated to

dryness on the Speed-Vac for FAB-MS analysis.
Each step in this isolation procedure was carefully evaluated
using mixtures of standard peptides and human urine samples, both
unspiked and spiked with known amounts of the standard peptides RF,
RPP, RPPG and RPPGF.

For urine samples, no more than 20 ml of urine

were loaded onto a double C Sep-Pak for the initial extraction
I8
step.

For higher volume urine samples, mUltiple extractions were

performed and the eluates pooled.

Subsequently, proportionate

aliquots of the eluate were loaded onto double Sep-Paks for the
second extraction, so that the same number of extraction operations
were performed during both steps.
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For the final evaluation of this isolation procedure, a 100 ml
sample of urine from a normal male human volunteer (25-35 year old
non-smoker on no prescription or over-the-counter medications) was
divided into 20 and 80 ml aliquots.

To the 20 ml aliquot were added

54 nmoles of RPP, 24 nmoles of RPPG and 35 nmoles of RPPGF.
80 ml aliquot was used as an unspiked control.

The

Both samples were

carried through the isolation procedure, and the final A3 and B3
fractions from both samples were analyzed by FAB-MS under low and
high resolution conditions.

The B3 fraction from the spiked sample

("RPPGF tt fraction) was also derivatized and analyzed by DIP-MS as
described below.

v.

Derivatization of RPPGF for DIP-MS analysis.
Using standard samples (10-120

~g)

of RPPGF, the following

procedure was developed for generating the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative of RPPGF in high
yield and purity for DIP-MS analysis at fairly low levels.
To the dry peptide were added 10
and 10

~l

of triethylamine.

vortexed and centrifuged.

~l

of water, 20

~l

of ethanol

The sample was capped under argon,
Acetylacetone (20

~l)

was added under a

stream of argon, and the sample was vortexed and heated at 100 °c
for one hour with occasional vortexing during heating.

The sample

was allowed to cool and evaporated to dryness on the Speed-Vac.
Schiff's bases were hydrolyzed by adding 100

~l

of water and 10

of glacial acetic acid to the sample and heating at 100 °C for

~l
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12 minutes with occasional vortexing.

The sample was then allowed

to cool and extracted three times with 200

~l

of diethyl ether.

The

aqueous sample was evaporated to dryness on the Speed-Vac, then
redissolved with sonication in 250-500

~l

of 0.1% TFA/water.

The

sample was then chromatographed by reverse phase ion pairing HPLC
using the acetonitrile/water/TFA system.

The region of the chromat-

ogram corresponding to DMPO-RPPGF was collected and evaporated to
dryness on the Speed-Vac.

The sample was then treated with

3 M methanolic Hel as described in section H above and, after
evaporation to dryness, the sample was redissolved with sonication
in 1 ml of 20% methanol/water/O.lio TFA.

The sample was chromato-

graphed by reverse phase ion pairing HPLC using the acetonitrile/water/TFA system, and the region of the chromatogram corresponding to
DMPO-RPPGF-O-methyl ester was collected and evaporated to dryness on
the Speed-Vac.
250

~l

Trifluoroacetylation was accomplished by adding

of chloroform and 50

~l

of MBTFA to the sample, vortexing and

allowing it to stand at room temperature for one hour.

The sample

was evaporated to dryness on the Speed-Vac, redissolved with sonication in 250-500

~l

of chloroform and chromatographed by normal

phase HPLC using the chloroform/methanol gradient system.

The

region of the chromatogram corresponding to DMPO-RPPGF-N-TFA-Qmethyl ester was collected and evaporated to dryness on the SpeedVac.

After redissolution in 50

ready for DIP-MS analysis.

~l

of chloroform, the sample was
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w.

DIP-MS analysis of standard RPPGF.
Standard samples (17-210 nmoles) of RPPGF were converted to the

DMPO-N-TFA-Q-ME derivative as described in section V above.
redissolution in 50

~l

of chloroform, 3-12

by repetitive scanning DIP-MS.

~l

After

aliquots were analyzed

Low and high resolution DIP-MS-SIM

analyses were accomplished with 6-18

~l

aliquots, monitoring m/z 746

(746.336 for high resolution), the molecular ion.

For DIP-CAD-

SRM-MS analyses, the mass spectrometer was set to monitor the
reaction where an m/z 746 ion decomposes to form an m/z 429 ion in
the first field-free region of the mass spectrometer, and 6-12

~l

aliquots were used for these analyses.

x.

DIP-MS analysis of RPPGF isolated from spiked human urine.
One third of the "RPPGF tI HPLC fraction (fraction B3) from the

human urine sample which was spiked with standard peptides
(35 nmoles of RPPGF) was derivatized to form the DMPO-N-TFA-Q-ME
derivative using the procedure described above.
iJ1..:~50

After redissolution

J.ll of chloroform, a 6 J.,Il aliquot was analyzed by low resolu-

tion (R=1,000-1,200) DIP-MS-SIM, monitoring m/z 746.

A second 6 J.ll

aliquot was analyzed by high resolution (R=14-15,OOO) DIP-MS-SIM,
monitoring m/z 746.336.

The sample (6 J.,ll) was then analyzed by

CAD-DIP-MS-SRM, monitoring the reaction where an m/z 746 ion decomposes to form an m/z 429 ion in the first field-free region of the
mass spectrometer.

Finally, a 12 J.ll aliquot was analyzed by repeti-

tive scanning DIP-MS at a resolution of 1,900-2,300.

CHAPTER III
RESULTS

A.

Feasibility of Q-TBDMS polyaminoalcohol derivatives.

The feasibility of incorporating O-t-butyldimethylsilylation
into the overall polyaminoalcohol scheme for peptides was tested
with the simple dipeptide AA.

Mass spectral analyses of the sequen-

tial derivatives leading to the formation of the N-trifluoroethyl-OTBDMS polyarninoalcohol derivative of AA are presented in Figures 3.1
through 3.4.

The FAB mass spectrum of the methyl ester derivative of AA
shown in Figure 3.1 demonstrates several features typical of FAB
mass ~pectra (61).

The sample has a nominal molecular weight of 174

and is ionized under FAB conditions to yield a pseudomolecular ion
+
([M+H] ) at m/z 175.

A series of glycerol clusters of the pseudo-

molecular ion appear at m/z 267, 359, 451, 543 and 635.

Each ion in

this series is incrementally 92 mass units (the molecular weight of
glycerol) heavier than its predecessor, and the ions in the series
are of successively decreasing intensity.

Also frequently observed

in FAB mass spectra is a protonated dimer of the analyte, which
appears at m/z 349 in Figure 3.1.

Most of the other prominent ions

in this spectrum (m/z 93, 185, 277, 369, 461, 553 and 645) are
background ions due to the glycerol matrix.

The combination of an

apparent pseudomolecular ion at m/z 175, a series of glycerol
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cluster ions starting at m/z 267 (175 + 92), and an apparent protonated dimer all form a body of evidence indicating that the analyte
has a molecular weight of 174 (61).

Similar features were observed

in many of the FAB spectra obtained during these studies, several of
which are presented below.

The spectrum in Figure 3.1 provides

strong evidence for the successful formation of the methyl ester of
AA.

A direct insertion probe electron impact mass spectrum of the
N-trifluoroacetyl-O-methyl ester derivative of AA is presented in
Figure 3.2.

As is typical of electron impact mass spectra, the

molecular ion is of low relative intensity.

The fragmentation

pattern is consistent with the expected structure of the derivative.
The sample was highly volatile, requiring little or no probe heating
to obtain a mass spectrum.
The FAB mass spectrum of the N-trifluoroethyl polyaminoalcohol
(free hydroxy group) derivative of AA (m.w. 214) is presented in
Figure 3.3.

The sample exhibits a prominent pseudomolecular ion at

m/z 215, with the typical series of glycerol cluster ions.
An electron impact mass spectrum of the N-trifluoroethyl-OTBDMS derivative of AA from repetitive scanning capillary GC-MS
analysis is presented in Figure 3.4.

The cleavage pattern evident

in the mass spectrum is consistent with that of the well known
N-trifluoroethyl-O-TMS polyaminoalcohols (17).

Additionally, the

spectrum exhibits the pair of ions corresponding to [M-15] + and
[M-57]+ as is characteristic of TBDMS derivatives.

The nomenclature
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used to indicate the ions useful for amino acid sequence determination (AI' A , etc.) in this and similar spectra below is that
2
published by Carr and co-workers (17).

The derivative was highly

volatile and eluted from a 30 m DB-5 capillary column at 120°C with
excellent GC properties.

This sample was also analyzed by FAB-MS,

and exhibited an intense pseudomolecular ion at m/z 329 (data not
shown).

These studies with AA indicated that volatile N-trifluoro-

ethyl-O-TBDMS polyaminoalcohol derivatives can be formed and have
potential utility for GC-MS studies of peptides.

B.

Compatibility of DMPO derivatives and diborane reduction.
The next question addressed during the course of these studies

was whether dimethylpyrimidylornithyl derivatives of arginyl residues are compatible with diborane reduction, i.e whether the dimethylpyrimidyl ring system is resistant to diborane reduction as
expected.

In order to address this question, dimethylpyrimidyl-

ornithine methyl ester was prepared at a semi-synthetic level and
treated with diborane using the procedure described by Carr and
co-workers (17).

The FAB mass spectrum of the methyl ester of

dimethylpyrimidylornithine (m.w. 252) is presented in Figure 3.5.
The spectrum exhibits a very intense pseudomolecular ion at m/z 253,
with a glycerol cluster ion at m/z 345 and a protonated dimer at
m/z 505.

The spectrum also exhibits an ion at m/z 267 which proba-

bly represents an over-methylated product which will be discussed
below.

Presented in Figure 3.6 is the FAB mass spectrum of the
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product isolated from the diborane reduction of dimethylpyrimidylornithine methyl ester.

The expected product, with the ester

group fully reduced to an alcohol group and with the dimethylpyrimidyl group unaffected, has a molecular weight of 224.

The FAB

mass spectrum is dominated by an extremely intense pseudomolecular
ion at m/z 225, with the ionization of the glycerol matrix suppressed.

Further evidence indicating that the dimethylpyrimidyl

group was not reduced by diborane is the presence of the fragment
ions at m/z 124, 136, 176, and 190, proposed structures for which
are presented in Figure 3.7.

These ions were observed in all of the

electron impact mass spectra of dimethylpyrimidylornithyl derivatives of arginine and arginyl peptides as will be presented below,
and in many of the FAB spectra, particularly those in which the
pseudomolecular ion was very intense as in Figures 3.5 and 3.6.

The

presence of these ions in Figure 3.6 indicates the presence of an
intact dimethylpyrimidyl group.

Hence it was concluded that the

dimethylpyrimidyl ring system is inherently resistant to diborane
reduction under the conditions employed.

c.

Trifluoroacetylation: methyl trifluoroacetate versus MBTFA.
In the most recently published version of the polyaminoalcohol

derivatization scheme, methyl trifluoroacetate is used for trifluoroacetylating the amino groups of peptides (17).

However, this

reagent was found to be inefficient for trifluoroacetylating the
amino termini of the arginyl peptides (as the
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Figure 3.7. Proposed structures for the ions of m/z 124, 136, 176
and 190 derived from DMPO derivatives of arginine and arginyl
peptides.
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dimethylpyrimidylornithyl derivatives) employed in these studies.
Evidence to this effect is presented in Figure 3.8, which is the FAB
mass spectrum of the product of the trifluoroacetylation of the
dimethylpyrimidylornithyl-O-methyl ester derivative of RF with
methyl trifluoroacetate.

The free amino precursor has a molecular

weight of 399, and that of the trifluoroacetylated product is 495.
Pseudomolecular ions corresponding to both the precursor and the
product are present in the FAB mass spectrum, indicating the incompleteness of the reaction with methyl trifluoroacetate.

Note that

the relative intensities of pseudomolecular ions in FAB mass spectra
are not necessarily correlated with the relative amounts present in
the sample;

the fact that two pseudomolecular ions are present an

FAB mass spectrum simply indicates that both compounds are present
in the sample.

Further evidence suggesting the inefficiency of

methyl trifluoroacetate for trifluoroacetylating these peptides was
provided by a series of samples of RF which were carried through the
entire derivatization process to yield the DMPO-N-TFE-O-TBDMS
polyaminoalcohol derivative for capillary GC-MS analysis, with the
trifluoroacetylation reaction time varied from twelve to thirty-six
hours.

Only those samples with prolonged trifluoroacetylation times

ultimately yielded strong GC-MS signals (data not shown).

This

reaction inefficiency is not surprising in light of some work
published by Steglich and Hinze in 1976 (62).

These investigators

studied the trifluoroacetylation of various amino acids with methyl
trifluoroacetate, and found that the trifluoroacetylation reaction
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time varied from ten minutes to forty-eight hours, depending on the
amino acid.

That the reaction time would vary from peptide to

peptide with this reagent is only to be expected.
However, in the context of an already time consuming derivatization process, a single step reaction time of 36-48 hours was
clearly unacceptable.

In order to circumvent this problem, a

procedure was developed employing N-methyl-bis(trifluoroacetamide)
(MBTFA) as a trifluoroacetylating reagent, with an overall reaction
time of 90 minutes.

Typical results with this procedure are pre-

sented in Figure 3.9, which is the FAB mass spectrum of the product
of the trifluoroacetylation of DMPO-RF-O-methyl ester with MBTFA.
The pseudomolecular ion corresponding to the trifluoroacetylated
product is present and very intense at m/z 496, while that corresponding to the precursor (m/z 400) is not significant compared to
the background.

This reagent consistently gave good results, and

the procedure was further refined during subsequent studies as
described below.

D.

Documentation of sequential derivatization reactions by FAB-MS.
A series of FAB mass spectra documenting the sequential deriva-

tization reactions leading to the formation of the DMPO-N-TFE-QTBDMS polyaminoalcohol derivative of RF are presented in Figures 3.10 through 3.14.

Each spectrum in this series exhibits an

intense pseudomolecular ion corresponding to the anticipated derivatization product.

All of these spectra exhibit at least one
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Figure 3.13. Fast atom bombardment mass spectrum of the dimethylpyrimidylornithyl-N-trifluoroethyl polyaminoalcohol derivative of
arginyl-phenylalanine (RF-DMPO-N-TFE polyaminoalcohol).
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glycerol cluster ion, and two spectra (Figures 3.10 and 3.11) show a
protonated dimer.

Fragment ions indicative of the dimethylpyrimi-

dylornithine side chain (m/z 124, 136 and 176) are intense in all
except Figure 3.12.

The m/z 190 fragment ion appears after the

reduction step, lending credence to the structure proposed for this
ion in Figure 3.7.

If this ion were present in the FAB mass spectra

of the non-reduced derivatives, this proposed structure would
clearly be invalid.
It should be noted that the spectra in Figures 3.10
through 3.14 were obtained after each successive derivatization step
was applied to a single 150 nmole sample of RF.

This was made

possible through the use of the technique where a small amount of
the solid or oily sample was removed from the sample vial and mixed
with glycerol directly on the FAB probe tip, leaving the majority of
the sample for further chemical treatment or analysis.

Serial

spectra were successfully obtained using these techniques starting
with as little as 15-25 nmoles of peptide sample and carrying
through the entire derivatization sequence.

By analyzing the

sequential steps by FAB-MS in this fashion, if a particular reaction
failed or was clearly inefficient, steps could immediately be taken
to correct the problem (e.g. repurification of reagents, alteration
of reaction conditions, etc.); otherwise, the existence of a problem
would only have been learned after failure of a GC-MS analysis, with
no indication as to which step was problematic.
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An additional example of these analyses is presented in Figure 3.15, which shows the FAB mass spectrum of the DMPO-N-TFE
polyaminoalcohol derivative of RPPGF (prior to silylation).

The

spectrum exhibits a prominent pseudomolecular ion corresponding to
the expected derivative at m/z 649, as well as numerous higher mass
ions which probably represent side reactions from the diborane
reduction.

Ions indicative of the dimethylpyrimidylornithine side

chain are present at m/z 124, 136, 176 and 190.

Additionally, two

fragments from the highly favored cleavage of the polyamine backbone
appear at m/z 358 and 372.

Due to space considerations, spectra

documenting the sequential derivatives of all of the peptides
studied will not be presented.

However, arginine and each of the

peptides RPP, RPPG and RPPGF were successfully analyzed by FAB-MS
after each step to document the sequential derivatives.

E.

Capillary GC-MS of arginyl peptides as DMPO-N-TFE-Q-TBDMS
ployaminoalcohol derivatives.
Electron impact mass spectra from repetitive scanning capillary

GC-MS analyses of arginine, RF, RPP, RPPG and RPPGF as the DMPO-NTFE-Q-TBDMS polyaminoalcohol derivatives are presented in Figures 3.16 through 3.20.

All of these derivatives exhibited excel-

lent gas chromatographic properties, with typical baseline to
baseline peak widths of 6-8 seconds on DB-1 capillary columns.
Temperatures of elution were 235°C for arginine (30 m column),
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295°C for RF (30 m column), 300°C for RPP (30 m column), 310°C
for RPPG (30 m column), and 320°C for RPPGF (5 m column).
The electron impact spectrum of fully derivatized arginine
presented in Figure 3.16 shows the series of fragment ions due to
the dimethylpyrimidylornithine side chain at m/z 124, 136, 176 and
190.

The related fragment ions at m/z 150 and 164, which are

evident in Figure 3.16, were not consistently observed in the
electron impact mass spectra of the arginyl peptides.

The ion at

m/z 275 represents cleavage on the carboxy side of the original
a carbon, the typical cleavage pattern for derivatives of this type.

Also noteworthy are the ions corresponding to [M-15]+ and [M-57]+
due to the loss of a methyl group and a t-butyl group from the TBDMS
moiety, respectively.
The cleavage patterns evident in the electron impact mass
spectra of the fully derivatized arginyl peptides in Figures 3.17
through 3.20 are directly analogous to those of the well known

N-TFE-O-TMS polyaminoalcohols (17), with primary cleavages occurring
on the carboxy side of the original a carbons of the polypeptide
chains.

Both A and Z series ions (17) are consistently observed in

all of these spectra.

Also consistently observed are the fragment

ions at m/z 124, 136, 176, and 190, which collectively may be
considered to be diagnostic for the dimethylpyrimidylornithine side
chain.

All of these spectra exhibit the pair of ions corresponding

to [M-15]+ and [M-57]+ as is characteristic of TBDMS derivatives.
These important ions form an easily recognizable pair which serves

68

as a punctuation mark for the mass spectrum, clearly denoting the
molecular weight of the fully derivatized peptide.

The molecular

ions of all of these derivatives were detectable under selected ion
monitoring conditions but were quite weak.

The derivatized brady-

kinin related peptides RPP, RPPG and RPPGF all have m/z 358 (the A2
ion) as the base peak in their mass spectra.

This was fortuitous

since it meant that all three peptides could be detected with good
sensitivity and molecular specificity simply by monitoring m/z 358
under capillary GC-MS-SIM conditions.
A representative chromatogram resulting from the derivatization
of a mixture of RPP, RPPG and RPPGF (17-27 nmoles of each) and
analysis by capillary GC-MS-SIM is presented in Figure 3.21.

The

three compounds were well resolved from each other and from interfering peaks on a 5 m DB-l capillary column, with excellent chromatographic properties.

The peak corresponding to RPP is offscale

(>80 V), and those corresponding to RPPG and RPPGF are of successively decreasing intensity.

This can be partially accounted for by

the fact that the m/z 358 ion represents an incrementally smaller
percentage of the total ionization of the sample as the length of
the peptide increases.

However, of greater importance is the

probability that the total yield of the final derivative decreases
as the length of the peptide chain increases, resulting in reduced
overall sensitivity for the longer peptides.

As the number of

peptide bonds increases, the likelihood of incomplete reduction
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Figure 3.21. Capillary GC-MS selected ion monitoring chromatogram
(monitoring m/z 358) of a mixture of RPP, RPPG and RPPGF. The
amount injected r~presented approximately 400 ng of each peptide.
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and/or incomplete decomposition of the highly stable bora amine
complexes formed during reduction increases.

F.

Methylation: ethereal diazomethane versus 3 M methanolic HCl.
When diazomethane was used as the methylating reagent in the

derivatization process, overmethylated products were observed by
FAB-MS (see Figures 3.5, 3.6, 3.8, and 3.11 through 3.14) and by
capillary GC-MS.

For instance, under GC-MS-SIM conditions (monitor-

ing m/z 358), RPPGF eluted as three well resolved peaks.

In light

of the high reactivity of diazomethane (63), this probably represents attack on the dimethylpyrimidyl ring system, although methylation of the amino terminus or amide nitrogen have not been ruled
out (overmethylated products were also observed with AA).

In

contrast, overmethylated products were not observed when 3 M methanolic HCl was used as the methylating reagent, as in Figure 3.21,
where all three peptides eluted as single peaks.

In order to

evaluate the effect of the choice of methylating reagent on overall
sensitivity, identical mixtures of RPP, RPPG and RPPGF (17-27 nmoles
of each) were derivatized for GC-MS-SIM analysis, with one mixture
methylated with diazomethane and the other with 3 M methanolic HCl.
The results of GC-MS-SIM analysis of the mixtures are presented in
Table 3-I.

Methanolic HCL is clearly the superior reagent for these

molecules, both from the standpoint of fewer side reactions, and
from that of a greater overall yield of the sought derivative, with
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TABLE 3-I
METHYLATION: METHANOLIC HCL VERSUS ETHEREAL DIAZOMETHANE
Peak signal intensities from capillary GC-MS-SIM analysis of
mixtures of 17-27 nmoles each of RPP, RPPG and RPPGF
Mixture
component

RPP
RPPG
RPPGF

Methanolic Hel
peak signal
intensity (V)

80
8.8
1.9

Diazomethane
peak signal
intensity (V)
40

2.2
not detected
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attendant better overall sensitivity.

Similar results were obtained

with repeated experiments.

G.

Sensitivity studies with DMPO-N-TFE-O-TBDMS polyaminoalcohol
derivatives.
In order to evaluate the lower limits of detectability

of

these peptides by these methods, a series of mixtures containing
from 20 pmoles to 27 nmoles of each of the peptides RPP, RPPG and
RPPGF were derivatized and analyzed by capillary GC-MS-SIM, monitoring m/z 358.

Some of the results of these studies are presented

in Figures 3.22 and 3.23.

Figure 3.22 shows the chromatogram

resulting from the derivatization and analysis of 20 pmoles of each
of the three peptides.

The tripeptide RPP was detected with an 80:1

signal to noise ratio, while RPPG and RPPGF were not detected.

The

chromatogram in Figure 3.23 resulted from the derivatization and
analysis of 270 pmoles of RPP, 120 pmoles of RPPG and 175 pmoles of
RPPGF.

The peak corresponding to RPP was offscale, RPPG was detect-

ed with a 12:1 signal to noise ratio, and RPPGF was not detected.
The lowest amount of the pentapeptide RPPGF that was derivatized and
definitively detected by capillary GC-MS-SIM was 1.7 nmoles (data
not shown).
Unfortunately, the results depicted in Figures 3.22 and 3.23
were not typical.

These results were very difficult to reproduce,

and the problem was traced to two primary sources.

The first of

these sources of poor reproducibility was rapid deterioration of GC
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Figure 3.22. Capillary GC-MS selected ion monitoring chromatogram
(monitoring m/z 358) of a mixture of 20 pmoles of each of the
peptides RPP, RPPG and RPPGF. The entire sample was injected. RPPG
and RPPGF were not detected.
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Figure 3.23. Capillary GC-MS selected ion monitoring chromatogram
(monitoring m/z 358) of a mixture of 270 pmoles of RPP, 120 pmoles
of RPPG and 175 pmoles of RPPGF. The entire sample was injected,
and RPPGF was not detected.
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column performance with repeated injection of low level samples.
During the derivatization process, oily reaction by-products gradually accumulate, to the extent that the final fully derivatized
sample may contain 1-2

~l

of oily contaminants.

Assuming that the

oil has a density of 1, this means that on a mass ratio basis, a
sample of 10 ng of peptide will have a contaminant to analyte ratio
of 10-20,000:1.

In order to detect these low level samples, the

entire sample was frequently injected, meaning that 1-2 mg of
unknown contaminants were co-injected with the low level analyte.
Such a contaminant load could easily destroy the performance of a
capillary column, particularly when heated to 320°C, the elution
temperature of the pentapeptide.

Extensive washing of the columns

with solvents followed by deactivation with 1,3-diphenyltetramethyldisilazane (64) did not restore column performance.

Furthermore,

deterioration of column performance occurred using both on-column
and splitless-split injection methods, indicating that the problematic contaminants have some degree of volatility.
The second source identified for the observed reproducibility
problems at low levels was the diborane reduction step of the
derivatization process.

The preceding three steps consisting of the

condensation with acetylacetone, methylation with 3 M methanolic
Hel, and trifluoroacetylation with MBTFA, all consistently yielded
the sought products as demonstrated by FAB-MS.

These three reac-

tions basically worked every time at both low and high levels.
reduction step, however, was quite variable in its yield of the

The
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sought polyaminoalcohol below a level of about 15-25 nmoles of these
peptides.

The irreproducibility of this reaction was most pro-

nounced with the longer peptides.

This is not surprising since the

probability of incomplete reduction and unwanted side reactions
increases as the number of peptide bonds increases.
The net result of these (and possibly other) sources of irreproducibility was that above a level of 15-25 nmoles, the DMPO-NTFE-O-TBDMS polyaminoalcohol derivatives of these peptides were
formed and detected with good reproducibility, although the derivative yield varied with the longer peptides even at these levels.
Below the 15 nmole level, reproducibility became a significant
problem.

H.

DMPO-N,O-di-TBDMS polyaminoalcohol derivatives.
In an effort to overcome some of the reproducibility problems

at low levels with the polyaminoalcohol derivatives, particularly
the problem of GC column deterioration, a brief study was undertaken
to examine the feasibility of employing DMPO-N,O-di-TBDMS polyaminoalcohol derivatives for the capillary GC-MS analysis of arginyl
peptides.

The procedure necessary for the formation of these

derivatives eliminates two steps as compared to their N-trifluoroethyl counterparts, namely the methylation and trifluoroacetylation
steps.

The trifluoroacetylation step could obviously be omitted,

and since the methylation step was only employed to facilitate
sample solubility in the triflouroacetylating reagents (17), this
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step was omitted as well.

Note that both ester groups and carbox-

ylic acid groups are reduced by diborane to an alcohol function, and
in fact the reaction occurs much more readily with the free carboxylic acid group than with the ester group (42).
The peptides RF, RPP and RPPG were successfully converted to
the DMPO-N,O-di-TBDMS polyaminoalcohol derivatives, and Figures 3.24
through 3.26 present their electron impact mass spectra from repetitive scanning capillary GC-MS analysis.

Like their N-trifluoroethyl

counterparts, these derivatives yield mass spectra which contain
complete amino acid sequence information including both A and Z
series ions, with the pair of ions corresponding to [M-15]+ and
[M-57]+ present in each to clearly denote the molecular weights of
the derivatives.

The fragments indicative of the dimethylpyrimidyl-

ornithine side chain at m/z 136, 176 and 190 are present in these
spectra.
These derivatives showed considerable promise from the standpoint of ultimate sensitivity.

Figure 3.27 presents a chromatogram

resulting from the injection of 80 pmoles of RPP as the DMPO-N,Odi-TBDMS polyaminoalcohol derivative under capillary GC-MS-SIM
conditions, monitoring m/z 390, the A2 ion.
exhibits a 2000:1 signal to noise ratio.

This chromatogram

Similarly, an injection of

1 pmole of RF yielded an excellent signal to noise ratio as depicted
in Figure 3.28.

Note that these samples were derivatized at the

150-300 nmole level and diluted prior to injection.
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Figure 3.24. Electron impact mass spectrum of the dimethylpyrimidylornithyl-N,O-di-TBDMS polyaminoalcohol derivative of arginylphenylalanine (RF-DMPO-N,O-di-TBDMS polyaminoalcohol) from capillary
GC-MS analysis.
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Figure 3.25. Electron impact mass spectrum of the dimethylpyrimidylornithyl-N,O-di-TBDMS polyaminoalcohol derivative of arginylprolyl-proline (RPP-DMPO-N,O-di-TBDMS polyaminoalcohol) from capillary GC-MS analysis.
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Figure 3.26. Electron impact mass spectrum of the dimethylpyrimidylornithyl-N,O-di-TBDMS polyaminoalcohol derivative of arginylprolyl-prolyl-glycine (RPPG-DMPO-N,O-di-TBDMS polyaminoalcohol) from
capillary GC-MS analysis.
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Figure 3.27. Capillary GC-MS selected ion monitoring chromatogram
(monitoring m/z 390) resulting from the injection of 80 pmoles of
RPP as the dimethylpyrimidylornithyl-N,O-di-TBDMS polyaminoalcohol
derivative.
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(monitoring m/z 176) resulting from the injection of 1 pmole of RF
as the dimethylpyrimidylornithyl-N,O-di-TBDMS polyaminoalcohol
derivative.
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While these derivatives do show promise, reproducibility
problems were encountered with them even at relatively high levels.
The sought derivative of the pentapeptide RPPGF was not definitively
identified during the course of these studies.

In addition to

reproducibility problems with the diborane reduction, the silylation
reaction presented problems as well.

With the N-trifluoroethyl

derivatives, the silylation reaction could be carried out in pyridine, which supresses the reaction of MTBSTFA with secondary amines
(46).

Unfortunately, this element of control was not possible with

the N,O-di-TBDMS derivatives, since pyridine also supressed the
silylation of the primary amine functions of these molecules.
Hence, the reaction was carried using acetonitrile as a solvent.
What was observed on several occasions was that the sought derivative was formed and existed for a short period of time (as little as
fifteen minutes), then converted to a higher mass compound which may
have been over-silylated.

Residual boron-containing contaminants

may have also participated in this conversion to an unknown high
mass product.

Because of these problems, these derivatives were not

pursued further during these studies.

I.

Selective extraction of arginyl peptides.
In order to explore the feasibility of selectively extracting

arginyl peptides from aqueous matrices, arginyl peptides were
treated with 1,2-cyclohexanedione and extracted using a combination
of immobilized phenylboronic acid columns and CIS Sep-Paks.

Samples
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of RF and RPPG so extracted and analyzed by FAB-MS exhibited pseudomolecular ions corresponding to the dihydroxycyclohexyl derivatives,
along with numerous contaminating species.

Upon treatment with

acetylacetone, the dihydroxycyclohexyl group was exchanged with
acetylacetone to form the highly stable dimethylpyrimidylornithyl
derivative, as was verified by FAB-MS.

A sample of 300 nmoles of RF

was extracted from phosphate buffered saline by these methods, then
derivatized to form the DMPO-N,O-di-TBDMS polyaminoalcohol derivative and analyzed by capillary GC-MS-SIM, monitoring m/z 176.
resulting chromatogram is presented in Figure 3.29.

The

Although this

chromatogram indicates that the extraction and derivatization
process are compatible, the intensity of the RF peak in Figure 3.29
is very low for the amount of sample represented.
were obtained with RPP.

Similar results

In order to determine whether this was due

to a derivatization problem or limited binding capacity in the
immobilized phenylboronic acid columns, a mixture containing
175-300 nmoles of each of the peptides RPP, RPPG and RPPGF was
extracted from phosphate buffered saline by these methods, and the
extract was analyzed by reverse phase ion pairing HPLC.

A blank

sample of phosphate buffered saline was treated identically in a
parallel experiment.
in Figure 3.30.

The resulting HPLC chromatograms are presented

Two conclusions may be drawn from these virtually

identical chromatograms.

First, this is clearly not an interfer-

ence-free system, as numerous contaminants appear in both chromatograms.

Secondly, very little peptide was extracted since at this
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Figure 3.29. Capillary GC-MS selected ion monitoring chromatogram
(monitoring m/z 176) of RF as the dimethylpyrimidylornithyl-N,O-diTBDMS polyaminoalcohol derivative, resulting from the extraction of
RF from phosphate buffered saline using the arginyl peptide selective extraction procedure.
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Figure 3.30. Analytical reverse phase ion pa1r1ng HPLC chromatograms of extracts of phosphate buffered saline (upper trace) and a
mixture of 175-300 nmoles of each of the peptides RPP, RPPG and
RPPGF in phosphate buffered saline (lower trace). The extracts were
obtained using the arginyl peptide selective extraction procedure.
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level of sensitivity, if the extraction were quantitative, the
peptides would have yielded peaks roughly half of a full scale
deflection in height, and would have been obvious as compared to the
blank control sample.

From these studies it was concluded that the

arginyl peptide selective extraction procedure, while workable with
standard samples, is probably impractical for application to complex
biological samples such as urine.

With the limited binding capacity

of the phenylboronic acid columns, the likelihood of interfering
species in biological samples effectively eliminating the binding of
the peptides of interest is very high.

J.

Reverse phase ion pairing liquid chromatographic isolation of
RPP, RPPG and RPPGF.
A procedure based entirely on ion pairing reverse phase liquid

chromatography was developed for the isolation of the bradykinin
related peptides RPP, RPPG and RPPGF from complex aqueous matrices,
particularly urine.

The procedure employs two reverse phase ion

pairing extraction steps using CIS Sep-Pak cartridge columns, with
selective elution of the peptides from the cartridge columns at each
step, and two reverse phase ion pairing HPLC isolation steps.
Throughout the procedure, advantage is taken of the differing
characteristics of the ion pairing reagents heptafluorobutyric acid
(HFBA) and trifluoroacetic acid (TFA).
Experiments with standard samples demonstrated that the peptides RPP, RPPG and RPPGF could be extracted from aqueous matrices
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and desalted using a CIa Sep-Pak with HFBA as an ion pairing
reagent.

The peptides could then be eluted from the Sep-Pak using

water saturated with diethyl ether as the eluting medium, leaving
strongly lipophilic materials adhering to the Sep-Pak.

After

removal of diethyl ether, the peptides could be re-extracted with a
CIS Sep-Pak with HFBA as the ion pairing reagent.

The more polar

peptides RPP and RPPG could then be eluted using 10% acetonitrile in
water, followed by a wash with 18% acetonitrile in water, and
finally the more lipophilic pentapeptide RPPGF could be eluted using
25% acetonitrile in water, again leaving highly lipophilic materials
adhering to the Sep-Pak.

During the second extraction step, the

sample is divided into two fractions: fraction Al contains RPP and
RPPG, and fraction B1 contains RPPGF.
Due to space considerations, the results of experiments with
standard peptides in simple aqueous media will not be presented.
Rather, the presented results will focus on experiments with urine
samples, particularly a 20 ml sample of human urine to which was
added 54 nmoles of RPP, 24 nmoles of RPPG and 35 nmoles of RPPGF
(spiked urine sample).

A blank (unspiked) urine sample was run in

parallel as a control.
An analytical HPLC chromatogram of the initial extract of a
20 ml urine sample, eluted from a Sep-Pak with water saturated with
diethyl ether, is presented in Figure 3.31.

Even with selective

elution, high levels of hundreds of compounds are co-eluted with the
bradykinin-related peptides.

This prompted the use of the second
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Figure 3.31. Analytical reverse phase ion pa1r1ng HPLC chromatogram
of the initial extract of a 20 ml human urine sample, selectively
eluted from an ODS Sep-Pak with water saturated with diethyl ether.
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extraction step, with further refined selective elution using
varying percentages of acetonitrile.
The next step in the isolation procedure is further purification of fractions Al and BI by reverse phase ion pairing HPLC, using
TFA as the ion pairing reagent.

Analytical HPLC chromatograms of

the Al and BI fractions from the spiked urine sample on the TFA
system are presented in Figures 3.32 and 3.33 respectively.

Peptide

components in the samples should be affected by the nature of the
ion pairing reagent to a greater degree than non-peptide components.
Since TFA is a much less lipophilic ion pairing reagent than HFBA
(52), by changing the ion pairing reagent from HFBA in the extraction steps to TFA in the first HPLC step, the elution positions of
the peptides of interest are shifted toward the earlier portions of
the chromatograms, with non-peptide lipophilic material eluting
later.

The indicated regions of the chromatograms were collected

under semi-preparative conditions to yield fractions A2 and B2.
This required multiple injections of both samples in order to
collect all of the material.
The final step in the isolation procedure is reverse phase ion
pairing HPLC of fractions A2 and B2 using the HFBA system.

Analyt-

ical HPLC chromatograms of these fractions from the spiked urine
sample are presented in Figures 3.34 and 3.35.

The large baseline

shift evident in these chromatograms is an artifact due to the HFBA
in the system.

The peptides of interest are shifted toward the

latter portions of these chromatograms relative to other components
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Figure 3.32. Analytical reverse phase ion pairing HPLC chromatogram
(TFA system) of the Al fraction from a spiked urine sample (20 ml
sample of human urine to which was added 54 nmoles of RPP, 24 nmoles
of RPPG and 35 nmoles of RPPGF). The indicated region (RPP and RPPG
region) was collected under semi-preparative conditions to yield
fraction A2.
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Figure 3.33. Analytical reverse phase ion pairing HPLC chromatogram
(TFA system) of the Bl fraction from a spiked urine sample (20 ml
sample of human urine to which was added 54 nmoles of RPP, 24 nmoles
of RPPG and 35 nmoles of RPPGF). The indicated region (RPPGF
. region) was collected under semi-preparative conditions to yield
fraction B2.
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Figure 3.34. Analytical reverse phase ion pa1r1ng HPLC chromatogram
(HFBA system) of the A2 fraction from a spiked urine sample (20 ml
sample of human urine to which was added 54 nmoles of RPP, 24 nmoles
of RPPG and 35 nmoles of RPPGF). The indicated region (RPP and RPPG
region) was collected under semi-preparative conditions to yield
fraction A3.
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Figure 3.35. Analytical reverse phase ion pairing HPLC chromatogram
(HFBA system) of the B2 fraction from a spiked urine sample (20 ml
sample of human urine to which was added 54 nmoles of RPP, 24 nmoles
of RPPG and 35 nmoles of RPPGF). The indicated region (RPPGF
region) was collected under semi-preparative conditions to yield
fraction A3.
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in the samples due to the use of HFBA as the ion pairing reagent.
The indicated regions were collected from multiple chromatograms to
yield fractions A3 and B3.

K.

FAB-MS analysis of RPP, RPPG and RPPGF isolated from spiked
human urine.
The FAB mass spectrum of fraction A3 isolated from the spiked

urine sample is presented in Figure 3.36.

For the sake of clarity,

only the portion of the spectrum encompassing the ions of interest
is displayed.

The molecular weights of RPP and RPPG are 368 and

425, respectively, and pseudomolecular ions corresponding to each of
these peptides are present in the spectrum at m/z 369 and 426.
Fortuitously, glycerol ionization was supressed with this sample,
which enabled the visualization of the pseudomolecular ion corresponding to RPP without interference from the m/z 369 background ion
due to the glycerol matrix.

Despite four successive steps of

purification, numerous other species are present in this sample.
Similar contaminant ions were in the blank urine sample as well, and
ions at m/z 369 and 426 were not significant compared to background
in the blank urine sample.

While the ions corresponding to RPP and

RPPG were not the most intense in this region of the spectrum in
Figure 3.36, they were nevertheless reasonably intense for the
amount of material represented in the spectrum.

In fact, these ions

were sufficiently intense to permit their visualization under FAB
conditions at a resolution of 6-7,000.

In order to better
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Figure 3.36. Fast atom bombardment mass spectrum of the A3 fraction
(RPP and RPPG fraction) from a spiked urine sample (20 ml sample of
human urine to which was added 54 nmoles of RPP, 24 nmoles of RPPG
and 35 nmoles of RPPGF).
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characterize the nature of the m/z 369 and 426 ions in this sample,
both ions were scanned at a resolution of 6-7,000 using the oscillographic recorder in order to visualize the peak profiles.

Then, the

authentic peptides were added to the glycerol-solvated sample, and
these ions were re-scanned.
ed in Figure 3.37.

The results of these scans are present-

In both instances, the ion of interest increased

in intensity while maintaining the peak profile of a single peak,
rather than appearing as a doublet in the presence of the authentic
peptides.

These results indicate that the isolated materials have

elemental compositions consistent with RPP and RPPG.
Figure 3.38 presents the FAB mass spectrum of the B3 fraction
isolated from the spiked urine sample.

The pseudomolecular ion

corresponding to RPPGF is quite intense at m/z 573.

Again, numerous

unknown species are present in the sample despite four steps of
purification.

This sample was not analyzed by FAB-MS under high

resolution conditions.

Rather, this sample was derivatized and

analyzed by DIP-MS methods as described below.

L.

Derivatization and DIP-MS analysis of standard RPPGF.
Since the pentapeptide RPPGF was consistently the most diffi-

cult to analyze of the peptides employed in these studies, efforts
were directed toward developing sensitive, specific and reliable
methodology for analyzing this peptide at reasonably low levels.
Toward this end, DIP-MS methods were developed employing the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester (DMPO-N-TFA-
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Figure 3.37. High resolution (R=6-7,OOO) fast atom bombardment mass
spectral analysis of the pseudomolecular ion regions corresponding
to RPP (m/z 369) and RPPG (m/z 426) of fraction A3 from the skiked
urine sample. The traces show the pseudomolecular ion regions
before (lower) and after (upper) the addition of authentic RPP and
RPPG to FAB sample.
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Figure 3.38. Fast atom bombardment mass spectrum of the B3 fraction
(RPPGF fraction) from a spiked urine sample (20 ml sample of human
urine to which was added 54 nmoles of RPP, 24 nmoles of RPPG and
35 nmoles of RPPGF).
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O-ME) derivative of RPPGF.

Unfortunately~

insufficient volatility for capillary GC-MS

this derivative possesses
analysis~

but it is

sufficiently volatile for DIP-MS, giving peak signal intensity with
the direct insertion probe tip at a temperature of approximately

250
10

-7

°C~

-10

with the ion source pressure maintained at approximately

-6

torr.

Figure 3.39 presents an electron impact mass

spectrum of RPPGF as the DMPO-N-TFA-Q-ME derivative from repetitive
scanning DIP-MS analysis.

The spectrum exhibits fragment ions

consistent with the expected structure of the derivative, including

the series of ions diagnostic for the dimethylpyrimidylornithine
side chain, and ions representing cleavage on both sides of the
carbonyl groups of all four peptide bonds.

Most notably, the

spectrum exhibits a surprisingly intense molecular ion at m/z 746,
roughly 20% as intense as the base peak in the spectrum, which is
quite unusual for an electron impact mass spectrum.

This intense

molecular ion was suitable for direct insertion probe selected ion
monitoring mass spectrometric analysis under both low (R=1,9002,300) and high (R=14-15,OOO) resolution conditions as demonstrated
in Figures 3.40 and 3.41, respectively.

Unfortunately, DIP-MS

methods suffer a loss of molecular specificity as compared to
capillary GC-MS methods.

In order to compensate for this loss of

specificity, methods were developed employing direct insertion probe
col1isionally activated dissociation selected reaction monitoring
mass spectrometry (DIP-CAD-SRM-MS) for the assay.

The reaction

wherein an m/z 746 ion decomposes to form an m/z 429 ion in the
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Figure 3.39. Electron impact mass spectrum of RPPGF as the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative
(RPPGF-DMPO-N-TFA-O-ME) from repetitive scanning DIP-MS analysis.

102

Figure 3.40. Low resolution (R=1,900-2,300) direct insertion probe
selected ion monitoring trace (monitoring m/z 746) of approximately
1 nmole of RPPGF as the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative (RPPGF-DMPO-N-TFA-Q-ME).
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Figure 3.41. High resolution (R=14-15,OOO) direct insertion probe
selected ion monitoring trace (monitoring m/z 746) of approximately
900 pmoles of RPPGF as the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative (RPPGF-DMPO-N-TFA-Q-ME).
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first field free region of the mass spectrometer was arbitrarily
chosen for these analyses (see Figure 3.39).

Figure 3.42 presents

an exemplary DIP-CAD-SRM-MS analysis of standard RPPGF.
The results presented in Figures 3.40 through 3.42 were obtained using samples derivatized at the 175 nmole level, with small
aliquots removed for analysis.

Initial efforts to reproduce these

results results using lower level samples (e.g. 10-20 nmoles)
failed, with little or no signal for the molecular ion of the
derivative detected by DIP-MS-SIM.

However, after the attempted

DIP-MS analyses, relatively large amounts of brown, obviously
decomposed material were observed in the DIP sample vials.

From

this, coupled with the fact that the presence of the sought derivative in the samples could be demonstrated by FAB-MS, it was concluded that accumulated reaction by-products from the serial derivatization steps were probably reacting with the derivative under the
heating conditions of DIP-MS, thus preventing the detection of the
derivative.
The obvious solution to this problem was separation of the
sought derivative from the problematic contaminants.

Toward this

end, HPLC isolation of the successive derivatives was incorporated
into the overall process, with the final derivative isolated by
normal phase HPLC.

Experiments with 17 nmole samples of RPPGF

demonstrated that the DMPO-N-TFA-O-ME could be formed, isolated and
successfully analyzed by DIP-MS using these methods.

Due to space

considerations, these experiments with lower levels of standard
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Figure 3.42. Direct insertion probe collisionally activated dissociation linked field selected reaction monitoring mass spectrometric
analysis of approximately 200 pmoles of RPPGF as the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative (RPPGF-DMPON-TFA-O-ME). The formation of an m/z 429 fragment ion from an
m/z 746 precursor ion was monitored.
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RPPGF will not be presented.

The results with the B3 ("RPPGF")

fraction isolated from spiked human urine are presented below.
An additional benefit of incorporating HPLC into the derivatization process was that it permitted visualization and quantitative estimation of the precursor, product, and some of the reaction
by-products of each of the three derivatization steps.

With the aid

of HPLC, the methods used in the acetylacetone condensation and
trifluoroacetylation steps were further optimized to maximize the
yield of the sought derivatives.

The methylation reaction consis-

tently yielded 90% or more of the sought methyl ester and was not
further opitmized.

M.

Derivatization and DIP-MS analysis of RPPGF isolated from
spiked human urine.

One third of fraction B3 from the spiked human urine sample
(representing approximately 12 nmoles of RPPGF) was derivatized to
form the DMPO-N-TFA-Q-ME derivative for DIP-MS analysis, with HPLC
isolation of the sequential derivatives.

The reverse phase ion

pairing HPLC chromatogram for the isolation of DMPO-RPPGF is presented in Figure 3.43.

The unreacted peptide eluted from this

gradient system at 25% acetonitrile concentration, and the DMPO
derivative eluted at 28% acetonitrile (these concentrations and
those below are corrected for the void volume of the system).

The

broad peak eluting at 41% acetonitrile represents a peptide-related
reaction by-product.

The formation of the DMPO derivative was

107

o

10

TiIne

20

30

(minutes)

Figure 3.43. Reverse phase ion pa1r1ng HPLC chromatogram (TFA
system) of the DMPO-derivatized B3 fraction from the spiked urine
sample. The indicated region of the chromatogram, corresponding to
RPPGF-DMPO, was collected.
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maximized and that of the by-product was minimized using the modified acetylacetone condensation procedure.

The indicated region of

the chromatogram was collected, dried, treated with 3 M methanolic
HCl and chromatographed by reverse phase ion pairing HPLC.
ure 3.44 presents the resulting chromatogram.

Fig-

RPPGF-DMPO-O-ME

eluted at 31% acetonitrile on this HPLC system, and the indicated
region of the chromatogram was collected and dried.

After tri-

fluoroacetylation, the sample was chromatographed by normal phase
HPLC using a chloroform-methanol gradient system.
chromatogram is presented in Figure 3.45.

The resulting

The downward baseline

drift evident in this chromatogram is due to the increased UV
transparancy of the solvent system as the methanol concentration
increases.

On this system, RPPGF-DMPO-N-TFA-Q-ME eluted at

15% methanol in chloroform, and the indicated region of the chromatogram

was collected.

The isolated derivative of fraction B3 from the spiked human
urine sample was analyzed by DIP-MS-SIM under low (R=1,900-2,300)
and high (R=15,OOO) resolution conditions, monitoring m/z 746, the
molecular ion of the sought derivative of RPPGF.

The resultant

DIP-MS-SIM profiles are presented in Figures 3.46 and 3.47.

Both of

these analyses exhibit a single peak consistent with the presence of
the RPPGF derivative.

The sample was next analyzed by the more

molecularly specific technique of DIP-CAD-SRM-MS, with the instrument set to monitor the formation of an m/z 429 ion from an m/z 746
precursor ion in the first field free region of the mass
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Figure 3.44. Reverse phase ion pairing HPLC chromatogram (TFA
system) of the DMPO-derivatized and methyl-esterified B3 fraction
from the spiked urine sample. The indicated region of the chromatogram, corresponding to RPPGF-DMPO-O-ME, was collected.
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Figure 3.45. Normal phase HPLC chromatogram of the DMPO-derivatized, methyl-esterified and trifluoroacetylated B3 fraction from
the spiked urine sample. The indicated region of the chromatogram)
corresponding to RPPGF-DMPO-N-TFA-O-ME) was collected.
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Figure 3.46. Low resolution (R=1,900-2,300) direct insertion probe
selected ion monitoring trace (monitoring m/z 746) of the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative of the
B3 fraction isolated from spiked human urine.
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Figure 3.47. High resolution (R=14-1S,OOO) direct insertion probe
selected ion monitoring trace (monitoring m/z 746) of the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative of the
B3 fraction isolated from spiked human urine.
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spectrometer.

Figure 3.48 presents the resultant profile.

single peak consistent with RPPGF is observed.

Again, a

The sample was then

analyzed by repetitive scanning DIP-MS, yielding the electron impact
mass spectrum presented in Figure 3.49, which is virtually identical
to that of the standard material in Figure 3.39.

As a final analy-

sis, roughly equal quantities of the derivatized B3 fraction and
derivatized standard peptide were mixed in a DIP sample vial and
analyzed by DIP-MS under high resolution (R=15,OOO)
conditions, scanning the molecular ion region of the mass spectrum
in raw data acquisition mode. The resultant peak profiles are
presented in Figure 3.50.

The molecular ion and the higher mass

isotope peaks appear as singlets, indicating that the elemental
composition of the derivatized standard peptide and the derivatized
B3 fraction are indistinguishable at this resolution.

Collectively,

the data presented in Figures 3.46 through 3.50 unambiguously
identify the presence of the pentapeptide RPPGF in the B3 fraction
from spiked human urine.
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Figure 3.48. Direct insertion probe collisionally activated dissociation linked field selected reaction monitoring mass spectrometric
analysis of the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl
ester derivative of the B3 fraction isolated from spiked human
urine.
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Figure 3.49. Electron impact mass spectrum of the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative of the B3
fraction isolated from spiked human urine, from repetitive scanning
DIP-MS analysis.
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Figure 3.50. High resolution (R=14-15,OOO) scan of the region of
the mass spectrum corresponding to the molecular ion of the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative of
RPPGF. The sample was a mixture of roughly equal quantities of the
derivatized B3 fraction and derivatized authentic RPPGF.

CHAPTER IV
DISCUSSION

A.

Polyaminoalcohol derivatives.
During the past thirty years, various forms of polyaminoalcohol

derivatives have been used for determining the amino acid sequence
of small peptides by gas chromatography-mass spectrometry.

These

derivatives have generally been used for the qualitative analysis of
high nanomole to micromole amounts of peptides, with very few claims
of successful qualitative or quantitative applications to lower
level peptide samples (30,65).

The application of these derivatives

to low level samples has not been restricted due to mass spectrometric sensitivity limitations; rather, the problem has been inherent
to the complex derivatization chemistry necessary for the formation
of these derivatives.

Detection limits have gradually been improved

over the years, but the ultimate sensitivity which could theoretically be obtained with these derivatives has not yet been approached
in practical terms.

The present studies have pointed out some of

the likely reasons for these persistent problems.

These studies

probably represent the first time that the sequential derivatives
generated by the successive derivatization steps have been analyzed
by direct chemical means, namely FAB-MS and, to some extent, HPLC.
Fast atom bombardment mass spectrometry has only recently become
generally available, and many advances in HPLC technology have been
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made during the past decade.

These factors rendered these sequen-

tial analyses possible, thus helping to identify some of the problems inherent in the most recently published version of the polyaminoalcohol derivatization scheme (17).
According to Carr and co-workers (17), ethereal diazomethane
and methanolic Hel may be used virtually interchangeably for methylating the carboxylic acid functions of peptides.

However, the

present studies demonstrated that methanolic Hel is the superior
reagent for this purpose.

Diazomethane is an extremely reactive

reagent (63), capable of reacting with with numerous functions
likely to be present in a peptide by a variety of mechanisms; thus
the use of diazomethane carries considerable risk of unwanted side
reactions.

Furthermore, peptides are generally poorly soluble in

diethyl ether, thus necessitating prolonged reaction times which in
turn increases the risk of side reactions.

Methanolic Hel, on the

other hand, is much less reactive than diazomethane, yet is a highly
efficient reagent for methylating carboxylic acid groups.

Further-

more, peptides are generally highly soluble in this reagent, thus
increasing the likelihood of a high overall yield of the sought
methyl ester.
Also in the paper published by Carr and co-workers, a procedure
employing methyl trifluoroacetate was presented as an optimized
means of trifluoroacetylating the amino functions of peptides.
procedure was found to be inefficient for the arginyl peptides
employed in these studies.

Steglich and Hinze (62) found that

This
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methyl trifluoroacetate reacts with different amino acids at varying
rates, requiring from ten minutes to forty-eight hours for complete
reaction, depending on the amino acid.

Similar variability of

reaction efficiency with different peptides is thus hardly

surprising.

The procedures developed during the present studies

employing MBTFA as a trifluoroacetylating reagent proved to be
highly efficient for the peptides studied, although whether these
procedures will be generally applicable to other peptides remains to
be determined.
The present studies demonstrated that employing the TBDMS group
for derivatizing the hydroxy functions of polyaminoalcohols offers
some significant advantages over the TMS group which has tradition-

ally been used for this purpose.

The TBDMS derivatives exhibit

hydrolytiC stability, which is not the case with TMS derivatives;
one sample of the DMPO-N-TFE-O-TBDMS polyaminoalcohol derivative of

RF, stored in pyridine solution at room temperature without special
precautions_ was stable for at least five weeks without apparent
decomposition.

Under electron impact ionization conditions, the

TBDMS derivatives give rise to a pair of ions corresponding to

[M-15]+ and [M-57]+; this easily recognized pair clearly denotes the
molecular weight of the derivative.

This information is frequently

not obvious from the [M-15]+ ions of TMS derivatives of polyaminoalcohols, which are typically of low intensity and may be easily
confused with chemical noise.

The potential disadvantage of slight-

ly reduced volatility of the TBDMS group as compared to TMS was

120

found not to be prohibitive, since the TBDMS derivatives were
sufficiently volatile for capillary GC-MS analysis of molecules as
large as the pentapeptide RPPGF.

The O-TBDMS polyaminoalcohol

derivatives may thus represent a new class of derivatives useful for
the amino acid sequencing of small peptides by GC-MS methods.
The present studies have shown that the condensation of the
guanidino groups of arginyl peptides with acetylacetone can be
successfully incorporated into the polyaminoalcohol scheme, thus
ensuring volatilization of the guanidino groups without the risk of
peptide bond cleavage.

This represents an improvement over the

hydrazinolysis method traditionally employed with the polyaminoalcohol scheme.

The reaction sequence employed for forming the

DMPO-N-TFE-O-TBDMS polyaminoalcohol derivatives is presented in
Figure 4.1.

These derivatives exhibit good volatility and excellent

capillary gas chromatographic properties for arginyl peptides as
large as RPPGF.

Under both electron impact and fast atom bombard-

ment ionization conditions, these derivatives generate several ions
diagnostic for arginyl residues.

The overall cleavage patterns

observed with these derivatives were typical of the polyaminoalcohols, and thus the new derivatives generate complete amino acid
sequence information in a fashion directly analogous to their well

known Q-TMS counterparts.
One of the goals of the present studies was to develop sensitive and reliable means of analyzing low level samples of arginyl
peptides.

Even with the improved derivatization methodologies
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Figure 4.1. Reaction sequence for forming dimethylpyrimidylornithyl-N-trifluoroethyl-O-TBDMS polyaminoalcohol derivatives of
arginyl peptides.
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developed during the course of these studies, the polyaminoalcohol
derivatives were not successfully utilized for this purpose.
Problems arose when attempting to extend the sensitivity limits of
these derivatives for quantitative purposes.

For qualitative

applications, e.g. repetitive scanning analyses, a threshold was
identified at around 10-20 nanomoles of peptide above which sufficient derivative was generated to permit consistent qualitative
identification of the peptides.

Below this threshold derivative

yield was quite variable, so that detection of the derivatives even
by the highly sensitive method of capillary GC-MS-SIM was only
sporadically successful.

The criterion for high reliability in a

quantitative method was thus not satisfied with the polyaminoalcohol
derivatives.

This judgement of poor reproducibility at low levels

was based upon many repeated experiments, during which as little as
20 picomoles of RPP were successfully analyzed, and during which as
much as 20 nanomoles of the pentapeptide were not successfully
analyzed.

Sporadic results such as these were clearly unacceptable

for a general analytical method.
Two major areas were identified as the probable sources for the
observed poor reproducibility with low level samples.

The first of

these was the diborane reduction reaction employed for converting
the polyamide peptide backbone to the more volatile polyamine
structure.

For many years, lithium aluminum hydride was the reagent

employed for this purpose. The use of diborane for the reduction,
originally developed by Frank and Desiderio (16) and later improved
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by Carr and co-workers, represented a significant advance for the
polyaminoalcohol derivatives in that it permitted the derivatization
and detection of lower level peptide samples than was possible with
lithium aluminum hydride.

However, the use of diborane still poses

problems, to the extent that two identical low level samples treated
identically by a single researcher can produce widely differing
results.

That the diborane reduction step was the problematic point

in the overall sequence was demonstrable by FAB-MS.

However, the

specific nature of the problem, whether it is incomplete reduction
of the polyamide backbone or ester groups, incomplete decomposition
of the highly stable boroamine complexes, or a problem with the
extraction process still remains unclear.

Throughout the long

history of the use of diborane for synthesizing secondary and
tertiary amines from substituted amides, the nature of the series of
reactions involved has never been rigorously elucidated.

Further

research on the nature of these reaction mechanisms could be of
considerable benefit to future efforts to extend the sensitivity
limits of the polyaminoalcohols.
The second source identified as a possible cause of the observed reproducibility problems with low level samples was residual
reagents and reaction by-products which accumulate during the
conversion of peptides to the fully derivatized polyaminoalcohols.
The derivatization of an arginyl peptide to form the DMPO-N-TFE-QTBDMS polyaminoalcohol involves treating the sample with ten successive reagents and reagent mixtures which consist of a total of
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sixteen different chemical species.

It is thus likely that the

observed oily contaminants consisted of mixtures of trace levels of
some of the derivatization reagents as well as by-products from the
individual reactions.

Accumulated contaminants from one reaction

sequence could certainly have interfered with a subsequent derivatization step.

Furthermore, with low level samples, the total

amount of the accumulated contaminants may have been several orders

of magnitude higher than the analyte, so that when nanogram quantities of the fully derivatized peptides were injected onto a capillary column, hundreds of micrograms of contaminants were coinjected.

Repeated injections of low level samples was observed to

cause rapid and irreversible deterioration of capillary column
performance, particularly with the larger peptides.

This was less

problematic with the higher level samples for qualitative analysis,
e.g. 20-50 nanomoles.

However, the observed deterioration of column

performance further reduced the reliability of the overall methods
for quantitative applications with low level samples.

The use of

HPLC for the isolation of the derivatives in high purity might
obviate this problem; however, the ultimate value of such a procedure would be questionable in light of the reproducibility problems
associated with the diborane reduction reaction.

The dimethylpyrimidylornithyl-N,O-di-TBDMS derivatives of
arginyl peptides which were briefly explored showed considerable
promise in terms of the amino acid sequence information generated
and the sensitivity for capillary GC-MS-SIM applications which might
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ultimately be obtained.

The reaction sequence employed for forming

these derivatives is presented in Figure 4.2.

One obvious advantage

offerred by these derivatives was the elimination of two major
derivatization steps and their attendant reaction by-products.

A

second potential advantage was the elimination of a possible unfavorable interaction due to the presence of both silicon and fluorine
in the fully derivatized N-trifluoroethyl derivatives.

During a

study of propranolol metabolism (66), Walle and co-workers found
that trifluoroacetyl derivatives partially decompose on gas
chromatographic systems previously used with TMS derivatives, to the
extent that entirely separate GC systems had to be used for the two
derivative types (67).

Similar results have since been obtained

from capillary GC-MS analysis of silylated and trifluoroacetylated
derivatives of adenosine (unpublished results from these laboratories).

The silicon-flourine bond is one of the strongest known

covalent bonds (68), and thus it was speculated that the observed
deterioration of capillary GC column performance might be related to
an unknown but highly favored anamolous interaction between siliconor flourine-containing species in the accumulated contaminants and
the derivatized peptides.

Unfortunately, the reproducibility

problems encountered with these derivatives prevented a complete
assessment of this possibility.

If reliable methodology for forming

these derivatives can be developed in the future t these derivatives
may prove to be very useful for both qualitative and quantitative
applications.
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B.

Isolation procedures.
The arginyl peptide selective extraction procedure which was

developed during the course of these studies was a modified version
of a procedure developed by Rose and co-workers (55).

While this

procedure was found to be workable with standard samples of arginyl
peptides in simple aqueous buffers, it was found not to provide the
interference-free, high yield extracts which were anticipated.

The

high levels of contaminating species in the extracts which were
observed by HPLC were probably residual reagents and reaction
by-products generated during the derivatization and extraction
process.

These contaminants likely contributed to the surprisingly

low binding observed with the phenylboronic acid columns employed.
Because of the high levels of interfering species and the low
binding capacity, this procedure was judged to be inappropriate for
application to complex biological samples such as urine.
In order to develop efficient and reliable means for isolating
bradykinin related arginyl peptides from complex matrices, advantage
was taken of the favorable properties of silica based reverse phase
matrices.

Both low and high resolution reverse phase columns

exhibit a high binding capacity with little risk of loss of low
level analytes.

Further advantage was taken of the shift in the

elution position of peptides relative to non-peptide species which
can be obtained through alternating the nature of the ion pairing
reagent employed in successive chromatographic procedures.

It was

serendipitously discovered that water saturated with diethyl ether
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containing heptafluorobutyric acid could elute all of the peptides
of interest from reverse phase cartridge columns, and this formed
the basis of one stage of selective elution.

While the overall

procedures developed were complex and time consuming, they nevertheless proved to be efficient means for isolating bradykinin related
arginyl peptides from human urine, which is an especially complex
matrix, and from which peptides are particularly difficult to
isolate.

It was reasoned that if these procedures could be success-

fully employed with the urinary matrix, they or variants of them
could be used with practically any biological matrix, most of which
are less complex than urine.

Indeed, for simple systems such as

cell culture supernatants, a single extraction followed by a single
HPLC isolation step, with alternating ion pairing reagents, would
probably prove sufficient for isolating these peptides in high
purity for further analysis.

It is anticipated that the isolation

methods developed during these studies will be beneficial for future
studies of bradykinin metabolism.

c.

Derivatization and DIP-MS analysis of RPPGF.
Because the pentapeptide RPPGF was consistently the most

difficult of the arginyl peptides studied to analyze by mass spectrometric means other than the relatively insensitive method of
FAB-MS, and because this peptide is one of the more likely metabolites of bradykinin, efforts were directed toward developing
sensitive, specific and reliable means of analyzing this compound.
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The dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester
derivative of RPPGF was employed for these studies.

The scheme

employed for forming this derivative is presented in Figure 4.3.
This derivative offered a significant advantage over the polyaminoalcohol approach in the simpler derivatization chemistry necessary
for its formation.

In particular, the use of this derivative

avoided the diborane reduction stept which was identified as a major
source of unreliability at low levels with the polyaminoalcohols.
Unfortunately, this derivative of the pentapeptide was insufficiently volatile for GC-MS analysis, and thus sufferred the disadvantage
of a loss of the molecular specificity afforded by capillary GC-MS
methods.

However, this derivative had the unexpected advantage of a

surprisingly intense molecular ion under electron impact ionization
conditions; this intense molecular ion proved suitable for both
selected ion monitoring and selected reaction monitoring, and thus
allowed a high degree of molecular specificity in the assay to be
regained.

A similarly intense molecular ion was also observed with

the dipeptide RF as the DMPO-N-TFA-O-ME derivative, which was
sufficiently volatile for GC-MS analysis (data not shown).

Thus,

this may be a general phenomenon with this type of derivative of
small arginy1 peptides.
Once again, accumulated contaminants from successive derivatization reactions threatened the reliability of the overall method
with low level samples by preventing the volatilization of the
derivative in the mass spectrometer.

With the pentapeptide, this
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Figure 4.3. Reaction scheme for forming the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative of RPPGF.
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problem was obviated through HPLC isolation of the three sequential
derivatives.

Normal phase HPLC permitted the isolation of the final

derivative in highly pure form, so that very intense signals were
consistently obtained from DIP-MS analysis of low level samples
under low resolution, high resolution and selected reaction monitoring conditions.

Furthermore, the inclusion of three HPLC isolation

steps in the derivatization process added an additional degree of
molecular specificity.
The use of HPLC also permitted further optimization of the
individual derivatization reactions.

During the acetylacetone

condensation reaction, a peptide related reaction by-product was
observed, the formation of which increased with the prolonged
heating conditions recommended in the literature (38).

The opti-

mized procedure developed during these studies permitted complete
consumption of the underivatized peptide with minimal formation of
this by-product.

The trifluoroacetylation reaction was also opti-

mized to permit maximal yield of the fully derivatized peptide.

The

overall yield of the derivative using the new procedures was estimated at 50-60%, as compared with around 20% with the non-optimized
procedures, based upon HPLC analysis.
These high-yield, high-purity derivatization methods, in
combination with the highly sensitive techniques of DIP-MS, permitted the unequivocal qualitative identification of RPPGF isolated
from spiked human urine at the 12 nanomole level (one third of a 35
nanomole sample).

These overall methods should be readily
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applicable to quantitative analyses with stable isotope labeled
internal standards.

D.

Conclusions.
The analysis of bradykinin metabolites could ultimately prove

to be a powerful means of evaluating the activity of the kallikreinkinin system.

From enzymatic and other studies, N-terminal frag-

ments of bradykinin are likely to be significant metabolites, and
may be useful for quantitating the flux of bradykinin through the
kallikrein-kinin-degradation system.

The studies described here

have focussed on developing means for isolating and analyzing the
N-terminal tri- through pentapeptide fragments of bradykinin with
high sensitivity, molecular specificity and reliability.

Efficient

but time consuming means for isolating all three of these compounds
have been developed.

The developed mass spectrometric analytical

methodology was most highly refined with the pentapeptide RPPGF
during these studies, but the new methods should be readily extendable to the shorter N-terminal peptides.

A relatively low level

(spiked) sample of RPPGF was successfully isolated and unequivocally
identified from the exceedingly complex biological matrix of human
urine.

It is hoped that the isolation and analytical techniques

described here will facilitate the elucidation of bradykinin metabolism in biological systems.
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INTRODUCTION

One of the techniques commonly employed in the separation of
enantiomers involves the preparation of diastereomeric derivatives
using an optically pure chiral derivatizing reagent.

The diastereo-

mers are then separated by various chromatographic means, and the
resulting elution patterns reflect the nature of the underivatized
material.

The purpose of the study presented here was to examine

the usefulness of O-(-)-menthyl-N,N'-diisopropylisourea as a reagent
for preparing (-)-menthyl esters of enantiomeric carboxylic acids.
Previously used methods for the preparation of menthyl esters
include acid catalyzed esterification using (-)-menthol (69).

This

method requires the use of dry hydrogen chloride gas and a very
large excess of (-)-menthol.

Menthyl esters have also been prepared

by first converting the acid to the acid chloride by refluxing with

thionyl chloride (70) or oxalyl chloride (71), followed by treatment
of the acid chloride with (-)-menthol.

While all of these methods

produce the desired end-product, namely diastereomeric (-)-menthyl
esters of enantiomeric acids, the derivatization procedures themselves are somewhat involved and require considerable care in the
maintenance of anhydrous conditions.

Among the proposed advantages

of O-(-)-menthyIN,N'-diisopropylisQurea «-)-MDI) as a chiral
derivatizing reagent are the simple techniques involved with its
use, the completeness of its reaction with carboxylic acids, and the
lack of potential racemization during derivatization.
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(-)-MDI is an adduct of (-)-menthol and N,N'-diisopropylcarbodiimide, as shown in Figure 5.1.
monovalent copper.

This reaction is catalyzed by

The derivatization reaction, depicted in Fig-

ure 5.2, produces the two diastereomeric esters and N,N'-diisopropylurea.

Tertiary amines catalyze the derivatizationj triethylamine

was used as the catalyst in these studies.
Naphthoxylactic acid (2-hydroxy-3-(1-naphthoxy)propanoic acid;
NLA), a major urinary metabolite of the a-adrenergic antagonist
propranolol, and mandelic acid were used as test samples for the
(-)-MDI reagent.
Figure 5.3.

The structures of these compounds are shown in

Both of these acids have one chiral center.

The

diastereomeric derivatives were analyzed by capillary gas chromatography (GC) and capillary gas chromatography-mass spectrometry

(GC-MS).
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MATERIALS AND METHODS

Synthesis of O-(-)-menthyl-N,NI-diisopropylisourea.
(-)-Menthol (7.8 g, 0.050 mol; Mallinkrodt, New York, NY, USA)
and N,N'-diisopropylcarbodiimide (6.3 g, 0.050 mol; Aldrich, Milwaukee, WI, USA) were dissolved in 25 ml tetrahydrofuran (Aldrich).
Copper(I) chloride (10 mgj Fisher, Fair Lawn, NJ, USA) was added,
and the mixture was stirred at room temperature overnight.

The

mixture was then evaporated in vacuo to 8 ml and chromatographed on
a 250 g Al 0 (W200 Basic, Woelm, Eschwege, GFR) column eluting with
2 3
250 ml tetrahydrofuran.

The tetrahydrofuran was removed by evapora-

tion in vacuo, yielding 5.86 g of (-)-MDI (41.6% of theoretical) as
a pale yellow liquid.

No appreciable decomposition of (-)-MDI was

detected four years after synthesis.

Other reagents.
(±)-Naphthoxylactic acid was prepared in these laboratories by
a procedure analogous to that reported by Nelson and Bartols (72).
Racemic mandelic acid was obtained from Chem Service (Westchester,
PA, USA); (-)-mandelic acid and (+)- mandelic acid were obtained
from Aldrich, triethylamine from Eastman Kodak (Rochester, NY, USA),
and ethyl acetate from Fisher.
or better.
(Aldrich).

All solvents were ACS reagent grade

Ethereal diazomethane was generated from Diazald
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Equipment.
Capillary GC analyses were performed using a Varian 3700 gas
chromatograph equipped with a split injector and a flame ionization
detector.

The column was a Grade A 60 m x 0.25 mm I.D. SP-2100 wall

coated open tubular (WeDT) glass capillary obtained from J&W Scientific (Orangeville, CA, USA).

The straightened capillary ends were

deactivated with Carbowax 20M.
Capillary GC-MS analyses were performed using the same gas
chromatograph and column interfaced through an open split interface
to a Finnigan MAT 212 mass spectrometer with a Spectrosystem SS200
data system.

Derivatization of enantiomeric acids.
A 1 mg amount of each sample acid was dissolved in 400

~1

~l

of

solution of tetrahydrofuran-triethylamine (9:1; v/v); 10

of a

(-)-MDI were added, and the reaction mixture was capped tightly in a
vial and heated at 100 °C for 16 hours.

The completeness of reac-

tion was monitored by forming the methyl ester of any unreacted acid
by derivatization with diazomethane in diethyl ether followed by
capillary GC analysis.

No methyl ester peaks were observed after

16 h heating with triethylamine as a catalyst.

Capillary GC-MS resolution of diastereomers.
The diastereomeric menthyl naphthoxylactates were resolved
under the following conditions: injector temperature 260°C; split
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ratio 1:350; column temperature programmed from 225°C to 240 °C at
a rate of 0.2 °C/min; average linear velocity 21-22 cm/sec; open
split interface temperature 260°C; ionization energy 70 eVe

The

conditions for the resolution of the diastereomeric menthyl mandelates were identical except that the injector temperature was 200°C
and the column temperature was programmed from 165 °C to 180°C at
0.3 °C/min.

Both analyses were complete before the final column

temperature was reached.

During both analyses the mass spectrometer

was scanned from 45 to 400 amu at a rate of 3 sec/decade with an
inters can time of 1 sec.

Determination of elution order.
Menthyl mandelates.

R-(-)-Mandelic acid and S-(+)-mandelic

acid were separately derivatized.

(In the Cahn-Ingold-Prelog system

of chiral notation, used here for the purposes of consistency,
D-(-)-mandelic acid has the R configuration.)

Aliquots of the two

solutions were mixed in a 4:1 (v/v) ratio (S:R and R:S) and analyzed
by capillary

Ge.

Elution order was determined based upon the

retention times of the separately derivatized Rand S standards and
the relative peak intensities of the two mixtures.
Menthyl naphthoxylactates.

Because of the unavailability of

optically pure R- and S- naphthoxylactic acid, and because NLA is a
major urinary metabolite of propranolol, R-naphthoxylactic acid was
extracted from the urine of a rat dosed with S-(-)-propranolol.

The

sample was a 24-hour urine collection from a male Sprague-Dawley rat
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injected intraperitoneally with 10 mg/kg of S-(-)-propranolol
hydrochloride (Ayerst Labs., New York, NY, USA).
volume was 14 mI.

The total urine

A 2 ml aliquot was adjusted to pH 1.5 with 6 N

hydrochloric acid and extracted with 2 x 5 ml of ethyl acetate.

The

combined organic phases were evaporated to dryness under a stream of
nitrogen; the residue was derivatized using 90
furan-triethylamine (9:1) and 10
this solution was mixed with 6

~l

NLA of comparable concentration.

~l

~l

of (-)-MDI.

of tetrahydroA 6

~l

aliquot of

of previously derivatized racemic
The resulting mixture was analyzed

by selected ion monitoring (m/z 370, the molecular ion) capillary
GC-MS.

The elution order was determined by comparing the relative

peak intensities of derivatized racemic NLA with and without the
added derivatized urinary R-NLA.
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RESULTS

(-)-MDI was found to react to completion with carboxylic acids
to form menthyl esters after 16 h heating in tetrahydrofuran with
triethylamine as a catalyst.
The retention behavior of the diastereomeric menthyl naphthoxylactates and menthyl mandelates from capillary GC-MS analysis is
presented in Table 5-I.

The retention times presented are adjusted

for the void volume of the system.

Exemplary chromatograms from the

two analyses are presented in Figures 5.4 and 5.5.

Figure 5.4 is a

retrospective single ion plot of the molecular ion (m/z 370) of
menthyl naphthoxylactate.

No molecular ion was observed for the

menthyl mandelates; the plot presented in Figure 5.S is a retrospective plot of m/z 107, corresponding to the [(C H )e(OH)H] + fragment
6 S
of menthyl mandelate.

Both sets of diastereomers were resolvable on

an SP2100 weOT capillary column with slight peak overlap.

Baseline

separation was obtainable under isothermal column conditions (225 °C
for the menthyl naphthoxylactates and 170 °C for the menthyl mandelates) with some sacrifice in analysis time and peak broadening.
The elution order of the menthyl mandelates was determined by
comparing the retention times of the separately derivatized optically pure mandelic acid enantiomers, and by comparing the relative
peak intensities of 4:1 (v/v) mixtures of the separately derivatized
enantiomers.

Under the conditions of the analyses, (-)-menthyl-

R-(-)-mandelate eluted with a peak maximum at 40.5 min (adjusted
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TABLE 5-I

RETENTION BEHAVIOR OF THE DIASTEREOMERIC MENTHYL NAPHTHOXYLACTATES
AND MENTHYL MANDELATES ON AN SP2100 weDT CAPILLARY COLUMN

Column
temperature

Adjusted
retention
time*
(min, ± 0.1)

Menthyl
naphthoxylactates

225-240 °C
at 0.2 °C/min

51.2
53.7

R-(-)

Menthyl
mandelates

165-180 °C
at 0.3 °C/min

40.5
42.6

R-(-)

Analysis

Carboxylic
acid
enantiomer

s-(+)

s-(+)

.... .I,.

An

***

* The elution time of a non-retained compound (butane) was subtracted from the absolute retention times to obtain the adjusted retention times.
** Determined from the data presented in Table 5-11.
*** Determined from chromatograms of derivatized optically
mandelic acid standards.
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Figure 5.4. Capillary GC-MS chromatogram of the diastereomeric
menthyl naphthoxylactates. A 3 ~l sample was injected (7-8 ~g) at a
split ratio of 1:350. The chromatogram is a ,retrospective single
ion plot of the molecular ion (m/z 370).
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Figure 5.5. Capillary GC-MS chromat~gram of the diastereomeric
menthyl mandelates, as a retrospective single ion plot of the
[{C6H5)C{OH)H]+ fragment (m/z 107) of menthyl mandelate. The sample
size was 3 ~l (7-8 ~g) injected with a split ratio of 1:350.
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retention time), and (-)-menthyl-S-(+)-mandelate eluted at 42.6 min.
These retention times were reproducible to within ± 0.1 min.

The

relative peak intensities of the two 4:1 mixtures were consistent
with the above elution order.
In order to determine the order of elution of the menthyl
naphthoxylactates, R-naphthoxylactic acid (R-NLA) was extracted from
the urine of a rat dosed with S-(-)-propranolol.

The shift in the

notation of the absolute configuration derives from the shift in
priorities in the Cahn-Ingold-Prelog system of notation.

It is

assumed that the chiral center of the a-blocking side chain of
propranolol remains unaltered during metabolism to NLA.

The ex-

tracted R-NLA was derivatized and mixed with derivatized racemic

NLA.

Table 5-II presents the relative peak intensities of this

mixture and those of derivatized racemic NLA alone (from selected
ion monitoring capillary GC-MS, monitoring m/z 370).

From the

results of the work of Nelson and Bartols (72), R-NLA is the negative rotating isomer.

(-)-Menthyl-R-(-)-naphthoxylactate was found

to elute before (-)-menthyl-S-(+)-naphthoxylactate on an SP2100
column.

150

TABLE 5-I1
DETERMINATION OF THE ORDER OF ELUTION OF THE DIASTEREOMER1C MENTHYL
NAPHTHOXYLACTATES FROM SELECTED ION MONITORING (m/z 370) CAPILLARY
GC-MS
Adjusted
retention time
(min, ± 0.1)

Relative
peak
intensity

Racemic NLA

51.2
53.7

0.95
1.00

Urinary R-NLA and
recemic NLA

51.2
53.7

1.50
1.00

Derivatized
sample
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DISCUSSION

O-(-)-menthyl-N,N'-diisopropylisourea has been synthesized and
found to be useful for the preparation of diastereomeric (-)-rnenthyl
esters of enantiomeric acids.

(-)-Menthy1 esters (from (-)-rnenthol)

have been used in the past in the diastereomeric separation of
lactic and glyceric acids (69), acyclic isoprenoid acids (70),
phytanic (73) and pristanic (74) acids, and chrysanthemic acids
(75).

The techniques involved with the use of (-)-MDI are relative-

ly simple, with the minor disadvantage of the requirement of overnight heating in order to effect completeness of reaction.

While

this study has demonstrated the applicability of (-)-MDI to analytical samples, it could be useful on a preparative scale as well.

For

instance, a large quantity of a racemic acid could be treated with
(-)-MDI, and the resulting diastereorners resolved by preparative
high performance liquid chromatography.

The separate esters could

then be hydrolyzed and the optically pure enantiomers isolated.
Such a procedure may offer advantages over repeated fractional
crystallization in terms of yield, purity, or both.
The determination of the order of elution of the menthyl
mandelates was straightforward due to the availability of optically
pure standards and the extremely reproducible retention times
obtainable from capillary GC techniques.

While the determination of

the elution order of the menthyl naphthoxylactates was indirect, it
afforded a further demonstration of the usefulness of (-)-MDI in its

152
application to the concentration levels of samples obtained from
biological fluids.

(-)-MDI thus has a wide range of potential

applications as an analytical tool, and could be useful for preparative work as well.

CHAPTER VI

RESOLUTION OF THE SEVEN ISOMERIC RING-HYDROXYLATED PROPRANOLOLS AS
tert.-BUTYLDIMETHYLSILYL DERIVATIVES BY CAPILLARY GAS CHROMATOGRAPHY-MASS SPECTROMETRY

Kevin D. Ballard, Daniel R. Knapp, John E. Oatis, Jr. and Thomas
Walle
Department of Pharmacology, Medical University of South Carolina,
Charleston, SC 29425
As published: J. Chromatogr. 277; 333-339, 1983.
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INTRODUCTION
Three previously unknown ring-hydroxylated metabolites of the
~-adrenergic

antagonist drug propranolol were recently identified by

Walle and co-workers (66).

In rats and in man, 2-hydroxypropranolol

(2-HO-P), 5-HO-P, and 7-HO-P were found, as well as the previously
known 4-HO-P (76-80), which is the major monohydroxylated urinary
metabolite of propranolol in both species, and the only hydroxylation product identified in the dog.

Briefly, these compounds were

identified in the following fashion.

Urine samples were treated

enzymatically to hydrolyze glucuronide conjugates; then the monohydroxypropranolols were extracted and analyzed as trimethylsilyl
(TMS) and trifluoroacetyl (TFA) derivatives by gas chromatography
(GC) and gas chromatography-mass spectrometry (GC-MS) using packed
column techniques (3% OV-1).

Identification of the isomers was

based upon comparison of retention times and mass spectra with those
of derivatized synthetic monohydroxypropranolols (66,81).

Two

derivatization techniques were employed because, under the conditions of the analyses, 2-HO-P and 8-HO-P were unresolved as TMS
derivatives, and 4-HO-P and 5-HO-P were unresolved as TFA derivatives.

Another complication encountered was that as TFA derivatives

the propranolol peak overlapped with the 2-HO-P peak, necessitating
the use of selected ion monitoring to distinguish these two compounds.

Furthermore, since TFA derivatives partially decompose on

columns previously used with TMS derivatives, separate columns had
to be used for the two types of derivatives.
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The purpose of the work presented here was to develop a simpler
technique for separating and identifying the seven isomeric ring-hydroxylated propranolols in order to facilitate future studies with
these compounds.

Such a technique has been developed, using a

relatively new silylating reagent, N-methyl-N-(tert.-butyldimethylsilyl)trifluoroacetamide (MTBSTFA), which produces volatile tert.butyldimethylsilyl (TBDMS) derivatives of aliphatic and aromatic
hydroxy groups (46), yielding mono-derivatized propranolol (TBDMS-P)
and di-derivatized hydroxypropranolols (TBDMS-HO-P), the structures
of which are presented in Figure 6.1.
When pyridine is used as a solvent for the derivatization,

secondary amines are derivatized very slowly by MTBSTFA (46); and,
with the TBDMS group attached to the aliphatic oxygen which occurs
far more rapidly in pyridine (46), derivatization of the secondary
amine group is further sterically hindered.

No tri-derivatized

hydroxypropranolols were observed during the course of this study.
(It may be possible to produce the tri-TBDMS derivatives with

acetonitrile as the solvent (45,46,59b) but these derivatives would
be expected to be less volatile than the di-TBDMS derivatives.)
Separations were carried out using glass capillary GC-MS.

The

applicibility of the method was demonstrated by analysis of a urine
sample from a rat dosed with (±)-propranolool and identification of
the ring-hydroxylated metabolites.
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Propranolol
T80MS-Hydroxypropranolol

Figure 6.1. Structures of ring-hydroxylated propranolol, TBDMShydroxypropranolol and TBDMS-propranolol.
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MATERIALS AND METHODS

Chemicals.
(±)-Propranolol hydrochloride was obtained from Sigma (St.
Louis, MO).

2-HO-P and 4- through 8-HO-P were synthesized as their

hydrochloride salts as previously described by Oatis and co-workers

(81); 3-HO-P (the least stable isomer) was freshly synthesized as
the free base according to the previously described procedure (81).
N-methyl-N-(tert.-butyldimethylsilyl)trifluoroacetamide (MTBSTFA)
containing 1% tert.-butyldimethylsilylchlorosilane was obtained from
Regis Chemical (Morton Grove, IL), and pyridine from Fisher (Fair
Lawn, NJ).

Equipment.

Capillary GC-MS analyses were performed using a Varian 3700 gas
chromatograph equipped with a split injector.

The column, a Grade

A, 60 m x 0.25 mm I.D. wall coated open tubular (WeOT) glass capillary obtained from J&W Scientific (Orangeville, CA), was interfaced
through an open split interface to a Finnigan MAT 212 mass spectrometer equipped with a Spectrosystem SS200 data system.

A fisher

Recordall Series 5000 stripchart recorder was used during selected
ion monitoring in analoque mode.
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Preparation of TBDMS derivatives of propranolol and monohydroxypropranolols.
A 1-1.5 mg sample of each compound was dissolved in 200
pyridine; 20

~l

~l

of

of MTBSTFA were added, and the reaction mixture was

tightly capped and heated at 100 °C for 2 h.

Derivatization of

8-HO-P is apparently sterically hindered, and requires 1-2 h heating
to drive it to the di-derivatized product.

The other compounds were

more readily derivatized, but all of the individual samples were
treated identically.

A mixture of propranolol and the seven monohy-

droxypropranolols (1-1.5 mg of each) was similarly derivatized using
100

~l

of pyridine and 120

~l

of MTBSTFA; this mixture required

heating for 16 h at 100°C to complete the derivatization of 8-HO-P.
The derivatives were stable in solution for at least two weeks.

Biological sample.
The hydroxypropranolol metabolites from a 2 ml aliquot of a
24 hour urine collection (total urine volume was 26 ml) from a male
Sprague-Dawley rat injected intraperitoneally with 10 mg/kg (±)-propranolol were enzymatically hydrolyzed and extracted according to
the method described by Walle and co-workers (66).
metabolites were derivatized using 100
MTBSTFA with 16 h heating at 100°C.

~l

The extracted

of pyridine and 20

~l

of
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Capillary GC-MS resolution of propranolol and the monohydroxypropranolols.
The TBDMS derivatives of propranolol and the seven isomeric
monohydroxypropranolols were resolved under the following conditions: injector temperature 240°C; split ratio 1:350; column
temperature programmed from 240 to 255 °C at a rate of 0.2 °C/min;
helium carrier gas average linear velicity 23-25 em/sec; open split
interface temperature 260°C; line-of-sight temperature 250°C; ion
source temperature 240 OCt ionization energy 70 eV.

During the

analyses of synthetic samples the mass spectrometer was scanned
repetitively from 30 to 550 amu at a rate of 3 sec/decade with an
inters can time of 1 sec.

Selected ion monitoring was used as the

detection system during the analysis of the biological sample
because of the enhanced sensitivity of this technique.

The mass

spectrometer was set to monitor m/z 217 using a direct probe sample
of TBDMS-derivatized 2-HO-P for calibration.

All of the compounds

eluted before the final column temperature was reached.
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RESULTS
The TBDMS derivatives of propranolol and the hydroxypropranolols
(with the exception of a-HO-p) were readily prepared using MTBSTFA
with pyridine as a solvent.

8-HO-P formed the di-derivatized

product less rapidly than the other hydroxypropranolols, but was
driven to completion with heating at 100°C for up to 16 h.

With

insufficient heating, two peaks were observed corresponding to monoand di-derivatized 8-HO-P, with the mono-derivatized product eluting
first.

With sufficient heating, only the later eluting peak was

observed.
Table 6-1 presents the elution order and the retention times of
the separately derivatized synthetic compounds; the retention times
presented have been adjusted for the viod volume of the system.

A

representative chromatogram of the results obtained when all eight
compounds were derivatized as a mixture is presented in Figure 6.2,
as a mass chromatogram of the sum of m/z 72, 217, and 274.

Proposed

structures of these ionic species are depicted in Figure 6.3.

A

profile essentially identical to that in Figure 6.2 was obtained for
m/z 72 alone, and the same profile minus the propranolol peak was
obtained for m/z 217 or 274 alone.

All three of these ions are

abundant in the mass spectra of the hydroxypropranolols, and each is
potentially suited for selected ion monitoring.

The m/z 217 and 274

ions are more specific for the hydroxypropranolols, as the m/z 72
ion is subject to interference from smaller molecular weight species
likely to be present in a biological sample.

Alternatively, the
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TABLE 6-1
ELUTION ORDER OF THE TBDMS DERIVATIVES OF PROPRANOLOL AND THE
MONOHYDROXYPROPRANOLOLS ON AN SP2100 weDT CAPILLARY CDLUMN*
Derivatized
compound

Adjusted retention
time** (min, ± 0.1)

Relative retention
time*** (± 0.01)

propranolol

14.7

8-HO-P
2-HO-P
3-HO-P
7-HO-P
4-HO-P
6-HO-P
5-HO-P

34.4
36.1
46.1
49.0
54.1
59.4
60.0

1.00
2.34
2.46
3.14

3.33
3.68
4.04
4.08

* The

column temperature was programmed from 240 to 255°C at a rate
of 0.2 °C/min.

**

The elution time of a non-retained compound (butane) was subtracted from the absolute retention times to obtain the adjusted
retention times.

*** Relative to TBDMS-propranolol.
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Figure 6.2. Capillary GC-MS chromatogram of the TBDMS derivatives
of propranolol and ring-hydroxylated propranolols, as a retrospective combined plot of three ionic species, m/z 72, 217 and 274 (see
Figure 6.3). The sample size was 3 ~l (100 ~g), injected with a
split ratio of 1:350.
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Proposed structures of the ionic species traced in
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molecular ion (m/z 503) could be monitored to enhance specificity
for the hydroxypropranolols, but with a sacrifice in sensitivity.
The TBDMS derivatives of propranolol and the hydroxypropranoloIs were well resolved on an SP2100 WeOT capillary column, with the
exception of 5- and 6-HO-P, which were separated by only 0.5-0.6 min
with an overall retention time of about 1 h.

This degree of resolu-

tion was obtained only when care was taken to ensure that the
initial average linear velocity was only slightly above the optimal
average linear velocity for the carrier gas (helium), so that the
system would approach maximum efficiency at the higher elution
temperatures.

Under a given set of flow conditions, capillary GC-MS

retention times were reproducible to within ± 0.1 min.
A selected ion monitoring (m/z 217) chromatogram of the TBDMS
derivatives of the ring-hydroxylated propranolol metabolites extracted from the urine of a rat dosed with (±)-propranolol is
presented in Figure 6.4.

The retention times of the peaks observed

from this sample were consistent with the observed retention times
of derivatized synthetic 2-, 7-, 4-, and 5-hydroxypropranolol run on
the same day.

The species identified by these techniques, and their

relative proportions, are consistent with the results previously
obtained in rats by Walle and co-workers (66).
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Figure 6.4. Selected ion monitoring (m/z 217) capillary GC-MS
chromatogram of the ring-hydroxylated metabolites of (±)-proprano!ol
extracted from rat urine. The sample size was 5 ~l (approximately
10 ~g) injected with a split ratio of 1:350. Peaks are labeled in
accordance with the retention times of derivatized synthetic compounds chromatographed on the same day.
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DISCUSSION
Propranolol and the seven ring-hydroxylated propranolols can be
separated and readily identified as TBDMS derivatives using capillary GC-MS techniques.

The identification methodology presented

here affords significant advantages over the techniques used in the
past (66).

The TBDMS derivatives are well suited for several

detection systems, including flame ionization (data not shown),
repetitive scanning mass spectrometry, ans selected ion monotoring
MS.

Only one derivatization technique is employed, eliminating the

necessity for using two separate GC columns.

TBDMS-propranolol is

well separated from the other seven compounds, so that special
techniques for distinguishing the parent compound from one of its
metabolites are not necessary.
The only major problem encountered using the techniques presented here was the moderate peak overlap between the TBDMS derivatives of 5- and 6-HO-P.

In order to ensure reliable identification

of these two compounds, care must be taken to ensure that the
capillary GC system is operating at near-maximal efficiency.
Problems concerning the identity of either or both of these two
compounds in a mixture may be overcome by adding a small quantity of
derivatized synthetic 5- or 6-HO-P and comparing relative peak
heights with and without the added compound.

The method presented

here should facilitate further studies of ring oxidation metabolic
pathways for propranolol, and should also be applicable to isomeric
metabolites of related compounds.

CHAPTER VII.

QUANTITATIVE ANALYSIS OF ADENOSINE: STATISTICAL COMPARISON OF
RADIOIMMUNOASSAY AND GAS CHROMATOGRAPHY-MASS SPECTROMETRY-SELECTED
ION MONITORING METHODS

K.D. Ballard, T.D. Eller, J.G. Webb, W.R. Newman, and D.R. Knapp
Department of Pharmacology, Medical University of South Carolina,
Charleston, SC 29425

R.G. Knapp
Department of Biometry, Medical University of South Carolina,
Charleston, SC 29425
As published: Biomed. Environ. Mass Spectrom. 13; 667-675, 1986.
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ABSTRACT
A new method for quantitating adenosine concentration by
capillary gas chromatography-mass spectrometry-selected ion monitoring (GC-MS-SIM) has been developed and used as a reference method
for evaluating a newly developed radioimmunoassay (RIA) for
adenosine.

Details of the GC-MS-SIM method are presented, along

with the comparative results and uncertainties of both methods.
General considerations in the statistical analysis of method comparison data are discussed with particular reference to studies using
quantitative mass spectrometry as the standard method;

the adeno-

sine methods are used as specific examples in this discussion.
Simultaneous estimation of the y-intercept and slope of the least
squares regression line relating the results of the two methods
using the 95% joint confidence ellipse demonstrated the absence of
either constant or proportional error between the two methods. The
relatively small uncertainty in the GC-MS-SIM measurements had no
significant effect on the linear regression.

Random error between

the two methods was detected, and was estimated by the coefficient
of variation in the RIA data as ten percent of the RIA value.
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INTRODUCTION
In method comparison studies, analytical techniques involving
quantitative mass spectrometry are being used with increasing
frequency as reference methods for determining the validity of other
quantitative analytical methods.

In a 1981 review article, Garland

and Powell (32) cited thirty-six such studies, and at least twentyfour similar studies have appeared since that time (83-106).

The

theoretical basis for using quantitative mass spectrometric methods
as reference or "standard" methods in such studies stems from the
high specificity and sensitivity for the compounds of interest
afforded by the mass spectrometer, particularly when combined with
the specificity of high resolution chromatographic techniques such
as capillary gas chromatography.

We have developed a new capillary

gas chromatography-mass spectrometry-selected ion monitoring
(GC-MS-SIM) method for quantitating adenosine, and have used this
method to evaluate a newly developed radioimmunoassay (RIA) for
adenosine.

The GC-MS-SIM method employs St,5'-dideuteroadenosine as

a stable isotope labeled internal standard, and uses the tetra-tbutyldimethylsilyl (tetra-TBDMS) derivatives of adenosine and its
dideuterated analog, with selected ion monitoring of the M-S7 ions
characteristic of TBDMS derivatives under electron impact ionization
conditions (44,45).

This chapter discusses details of the GC-MS-SIM

method and the comparison of the results of this method with those
obtained with the radioimmunoassay.
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In evaluating one analytical method using another "standard tl
method one is faced with the problem of how to compare the data in a
statistically valid manner and how to arrive at a quantitative
measure of the nature and magnitude of errors in the method under
examination.

The use, and misuse, of statistical techniques in

comparisons of analytical methods have been discussed previously
(107-111).

In this paper we discuss the use of statistical tech-

niques in method comparison studies using quantitative GC-MS-SIM as
the reference method, with application to the adenosine methods as a
specific example.
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MATERIALS AND METHODS
All glassware used in these experiments was silanized.
Chemicals.

S',S,_[2H2J-adenosine (112) (isotopic purity estimated at
greater than 98%) was a generous gift from Karl H. Schram (University of Arizona, Tucson, AZ).

Unlabeled adenosine and n-dodecane were

reagent grade from Aldrich Chemical Co. (Milwaukee, WI).

Glass-

distilled water was generated in these laboratories, and DistilledIn-Glass grade methanol and acetonitrile were obtained from Burdick
and Jackson Laboratories, Inc. (Muskegan, MI).

N-Methyl-N-t-butyl-

dimethylsilyltrifluoroacetamide (MTBSTFA) was obtained from Regis
Chemical Co. (Morton Grove, IL).

All other chemicals were reagent

grade from commercial sources and were used without further purification.
Unknown samples.
Thirty-nine unknown samples were used for comparative measurements of adenosine concentration by RIA and GC-MS-SIM.

Thirty-six

of these were coronary effluent samples from Langendorf style
perfused guinea pig hearts.

The perfusing medium was a modified

Krebs-Henseleit solution (113) (KHS), equilibrated with 95% OXYgen-5% carbon dioxide, and containing NaCI (127.2 mM) KCl (4.7 roM),
CaC1

2

(2.5 roM), KH P0 (1.2 mM), MgS0 (1.1 mM), NaHC0 (24.9 roM),
4
3
2 4

sodium pyruvate (2.0 mM), and glucose (5.5 mM).

Samples were taken

under control conditions and after various pharmacological manipulations including infusion of adenosine and bolus injections of

172
isoproterenol.

All coronary effluent samples were collected for 30

seconds and immediately immersed in boiling water for 5 minutes in
order to denature any degradative enzymes released from the heart.
The three remaining unknown samples were left ventricular
tissue extracts.

Portions of left ventricle (approximately 100 mg)

were quickly frozen between two copper blocks precooled with dry
ice.

The frozen tissue samples were homogenized with a Polytron

homogenizer in 1 ml of ice cold 10 mM Tris Hel, pH 7.2.

R

The homo-

genate was acidified with 1 ml of 14% trichloroacetic acid, then
centrifuged.

The supernatant was decanted and saved.

The pellet

was resuspended in 2 ml of 7% trichloroacetic acid, centrifuged, and
the supernatant combined with the first.

The combined supernatant

was neutralized with sodium hydroxide prior to analysis by RIA and
GC-MS-SIM.
The results of the biological experiments have been published
elsewhere (114).
Preparation of standard samples and internal standard solution for
GC-MS-SIM analysis.
Standard samples ranging in concentration from 1 to 100 ng/ml
in adenosine concentration were prepared by serial dilution in KHS.
The initial solution from which serial dilutions were made was
freshly prepared to four significant figures at the start of each
analysis.
ng/100

~l

An internal standard solution containing approximately 40
dideuteroadenosine in KHS was also freshly prepared for

each analysis.
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Addition of internal standard.
An aliquot (1 ml) of each standard and unknown sample was
pipetted into a polypropylene tube (17 x 100

mm~

Elkay Products).

For unknown samples out of the range of the standard curve according
to previous analysis, smaller aliquots were diluted with KHS to a
final volume of 1 ml to bring them into range.
dard solution (100

~lJ

The internal stan-

40 ng) was then added to each sample.

Control samples included a blank sample of KHS (1 ml), to which the
internal standard was added, and an additional 1 ml aliquot of the
100 ng/ml adenosine standard solution, to which no internal standard
was added.

All samples were vortexed and allowed to equilibrate for

30 minutes.
Extraction of adenosine with reverse-phase cartridge columns.
Because buffer salts can interfere with silylation reactions,
all samples were desalted using reverse-phase cartridge columns.
separate CIS Sep-Pak

R

was used for each sample.

columns were charged with 10 ml of
of water.

A

The cartridge

methanol, and washed with 10 ml

The samples were then loaded, washed with 10 ml of water

to effect desalting, and finally eluted with 2.5 ml of 40% (v/v)
aqueous methanol.

The samples were eluted directly

sealable ampules (Wheaton).

i~to

10 ml

Eluting solvent was removed by evapora-

tion under a stream of nitrogen in a boiling water bath.
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Formation of the tetra-TBDMS derivatives of adenosine and dideuteroadenosine.
To each dry sample were added 100

~l

of MTBSTFA and 400

~l

of

acetonitrile.

The ampules were sealed and heated for five hours in a wax

bath maintained at 150 °C.

The ampules were then opened, and the

contents transferred to 1 ml Reacti-Vials

R

(Pierce).

Excess deriva-

tization reagent
and solvent were removed by evaporation under a stream of nitrogen
in a 40°C
water bath.
tion in 20

The derivatized samples were redissolved with sonica~l

n-dodecane.
GC-MS-SIM.
Quantitative GC-MS analyses were performed using a Varian 3700
gas chromatograph interfaced to a Finnigan MAT 212 mass spectrometer
equipped with a Spectrosystem 8S200 data system with selected ion
monitoring hardware.
0.25

~m

The GC column was a 30 m DB-5 (0.259 rom i.d.,

film thickness, J & W Scientific) fused silica capillary

column, the outlet end of which was introduced directly into the ion
source of the mass spectrometer through a heated transfer line
maintained at 290°C.

The gas chromatograph was equipped with an

on-column injector and utilized helium carrier gas with a capillary
head pressure of 35 psi (average linear velocity 40-45 em/sec at the
upper GC oven temperatures).

A sample, typically 3

~l,

was slowly
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injected on-column with the GC oven at 225°C; after the solvent had
passed through the column, the oven temperature was rapidly ramped
to 280 °C, then programmed to 300°C at 3°C/minute.
The mass spectrometer was operated in electron-impact mode (70
eV ionization energy, 1 rnA emission) with the ion source at 220°C,
and a typical source pressure of 1 x 10

-5

torr.

Mass spectral

resolution was set at 700 with a flat-topped peak shape.

Ion source

potentials were optimized while monitoring the m/z 207 column bleed
peak with the GC oven at 300 °C.
The magnet was operated in current regulation mode for stability.

The magnetic field was manually set to focus m/z 666.4 at the

nominal accelerating voltage of 3 kV; magnetic focusing was checked
immediately prior to each sample injection in order to correct for
any drift in magnetic field strength.
The ion intensities at m/z 666.4 and 668.4 were monitored by
alternating the accelerating voltage only (no magnetic jumping was
employed).

The intensity corresponding to each ion was recorded 10

times per second, with each recorded measurement being the average
of 16 individual measurements.

This high rate of sampling was used

in order to maximize the precision of the ion intensity area ratio
measurements from narrow capillary GC peaks.

The areas under the GC

ion intensity profiles were measured using the standard software
with the SS200 data system.
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Data reduction
The 666/668 ion intensity ratio measurements were converted to
(~/y,

idealized mole ratios

sample to internal standard) using

equation (1) (115):
(Ry - Rm) (Rx + 1)

x
=

y

(1)

(Rm -

Rx) (Ry + 1)

where Rx is the 666/668 ion intensity ratio for pure unlabeled
sample, Ry is the corresponding ratio from the pure internal standard, and Rm is the ratio for each mixture.

The utility of this

equation has been discussed thoroughly in the literature (115,116).
Standard curves were generated by plotting

~/~

calculated from the

known samples versus the adenosine concentration.

The !/I ratio was

calculated for each unknown sample, and the adenosine concentration
calculated from the standard curve; any necessary corrections for
sample dilution were then applied.
Radioimmunoassay.
A detailed description of the new RIA for adenosine is beyond
the scope of this manuscript.

Briefly, the antiserum was raised in

rabbits using an immunogen of 2',3'-O-disuccinyl adenosine coupled
to bovine serum albumin with isobutyl chloroformate.

Free and bound

adenosine were separated using dextran-charcoal, with iodinated
tyramine bound to disuccinyl adenosine used as a tracer.
detection limit was established at

approx~ately

The

280 pg/ml.

Speci-

ficity studies employing a series of related compounds showed
maximum cross reactivities of 1.7% for deoxyadenosine and 0.06% for
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adenosine monophosphate.

The intraassay coefficient of variation

averaged 3.2%, and the interassay coefficient of variation was 3-5%.
RIA linear transformation
The standard linear transformation for radioimmunoassay data
was used, where the logit of BIB

m

(binding over maximal binding) is

plotted against the logarithm of adenosine concentration (117).
Statistics
The lines of best fit for the linearly transformed standard
curves from both GC-MS-SIM and RIA analyses were calculated using
classical least squares linear regression techniques (118).

For

both standard curves, 95% confidence limits on X values calculated
from measured Y values were determined using the 95% inverse tolerance limits for the entire regression line as described by Williams

(118).
Several statistical calculations were employed in comparing the
RIA and GC-MS-SIM quantitative results.

The y-intercept and the

slope of the line relating [AJ R1A (y) and [A]GCMS (X) were calculated using classical least squares procedures (118), as were the
independent tests for the significance of the y-intercept and the
slope.

The 95% joint confidence ellipse for testing the hypothesis

that the y-intercept and slope are simultaneously a and 1 respectively was generated as described by Neter and Wasserman (119).
Deming's method for determining a linear equation for data involving
errors in both ordinate and abscissa was employed in the manner
described by Cornbleet and Gochman (111).
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RESULTS AND DISCUSSION
Mass spectra of the tetra-TBDMS derivatives of adenosine and
S',S'-dideuteroadenosine are presented in Figure 7.1.

The fragmen-

tation patterns in these spectra are very similar to those described
for trimethylsilyl derivatives of nucleosides by Pang and co-workers
(120).

The molecular ion regions of both spectra are of very low

intensity, while the M-S7 ions, characteristic of TBDMS derivatives
(44,4S), are prominent in both.

The molecular ions and fragment

ions involving the ribose (sugar) moiety (S) differ by two m/z units
between the two spectra, while fragments involving the base (B) but
not the ribose are identical.

The M-S7+2 ions are also prominent in

these spectra; since m/z 666 and 668 were the ions monitored for
quantitative GC-MS analysis, the presence of an intense m/z 668 peak
in the unlabeled spectrum presents an ion overlap problem (121), as
will be discussed below.

The base peak in these spectra, m/z 73,

was identified as the rearrangement ion [(CH3)3Si]+ by measuring its
exact mass by high resolution (R=10,000) direct probe mass spectrometry with peak matching against the m/z 69 ion of perfluorokerosene
(theoretical exact mass 73.0474 amu; experimental 73.0470 amu).
Representative GC-MS-SIM traces at m/z 666.4 and 668.4 from a
perfusate sample are presented in Figure 7.2.

The tetra-TBDMS

derivative of adenosine has excellent chromatographic properties on
a fused silica DB-S capillary GC column, and retention times were
reproducible to within ± 3 seconds. The SIM traces were entirely
free of interference in this region of the chromatogram.
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Figure 7.1. Averaged, background subtracted repetitive scanning
mass spectra of the tetra-TBDMS derivatives of adenosine (A) and
5',5'-dideuteroadenosine (B).
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A plot of the 666/668 ion intensity ratio versus the adenosine
concentration from the standard curve data was hyperbolic, asymptotically approaching the ratio for pure derivatized unlabeled adenosine as the relative concentration of internal standard decreased.
This phenomenon occurred because of the presence of the m/z 668 peak
in the mass spectrum of the unlabeled material (Figure 7.1A), and
necessitated the use of a linear transformation on the standard
curve data, which was performed using equation (1) as recommended by
Colby and McCaman (115).

The standard curves of the transformed

data (Figure 7.3) were linear over the 1-100 ng/ml adenosine concentration range, with a typical correlation coefficient of 0.9998.

At

higher levels of adenosine concentration (e.g. 500 ng/ml), propagated errors reached an unacceptable level (115), thus limiting the
upper end of the standard curve to 100 ng/ml with 40 ng/ml internal
standard.

The lower end of the range was dictated by the anticipat-

ed lowest concentration of the samples to be analyzed (5-10 ng/ml),
and was not due to sensitivity limitations.

The GC-MS-SIM methodol-

ogy described here should be useful in the picogram per milliliter
range, with an appropriate reduction in the amount of added internal
standard.
The derivatization reaction was not complete under the conditions employed, with approximately 30-35% of the adenosine driven to
the tetra-derivatized form.

However, variations in extraction and

derivatization efficiency were well accounted for through the use of
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the stable isotope labeled internal standard, as evidenced by the
excellent linearity of the transformed standard curve.
Also shown in Figure 7.3 are the 95% inverse tolerance limits
for the GC-MS-SIM standard curve regression line.

These were used

to place confidence intervals on calculated X values (adenosine
concentration) from measured, transformed Y values
formed 666/668 ion intensity ratio).

(~/y,

the trans-

While actually hyperbolic,

these two lines are approximately parallel to the regression line,
giving a 95% confidence band of ± 2 ng/ml across the entire range of
the standard curve.

This establishes the lower limit of quantita-

tion with this standard curve at around 5 ng/ml, since at the lower
standard concentration, 1 ng/ml, the uncertainty is larger than the
known value.

For concentrations below 5 ng/ml, a new standard curve

covering a lower range of concentrations would be needed.

The

lowest level of adenosine concentration in an unknown sample measured in these analyses was 5.0 ± 2.1 ng/ml.
Figure 7.4, a typical linearly transformed standard curve from
RIA analysis, shows the 95% inverse tolerance limits on the logarithm of adenosine concentration.

By definition, these tolerance

limits are hyperbolic, and thus automatically incorporate the
heteroscedacity (nonconstant variance) inherent in RIA measurements.
However, both the RIA and GC-MS standard curves exhibited excellent
linearity, and the hyperbolic nature of the tolerance limits,
although present, is not visually apparent in either standard curve.
For the RIA analyses, application of the inverse tolerance limits
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equation to an unknown sample yielded 95% confidence limits for the
logarithm of adenosine

concentration~

which, when exponentiated,

generated a confidence interval for adenosine concentration.

This

confidence interval is asymmetric due to the logarithmic nature of
the standard curve.
The comparative results between RIA and GC-MS-SIM analyses are
plotted in Figure 7.5, with Figure 7.SA covering the entire range of
observations (5 to 3000 ng/ml), and Figure 7.SB expanded to show the
cluster of values in the 5-300 ng/ml range.

(The higher concentra-

tions were measured by GC-MS by diluting the sample into the 1-100
ng/ml range.)

The vertical bars indicate the 95% confidence limits

on [A] for each sample from RIA analysis, and the horizontal bars
show the corresponding 95% confidence limits for fA] from GC-MS-SIM
analysis.

The estimated regression line relating [A]RIA (Y) and

[A]GCMS (X) obtained by classical least squares analysis is shown as
the solid line.

The ideal relationship between the two methods

occurs when identical results are obtained with both methods, and is
represented mathematically by the functional relationship Y=X or
[A]RIA

=

[A]GCMS·

This relationship occurs when the regression line

relating [A]RIA and [A]GCMS has simulatneously a y-intercept and
slope of zero and

one~

respectively.

This ideal line of identity is

represented by the dashed line in Figure 7.5.

In order to investi-

gate the agreement of the results of the two methods, it is necessary to test the hypothesis that the true (population) y-intercept
and slope of the estimated regression line relating [A]RIA and
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[A]GCMS do not deviate significantly, in the statistical sense, from
zero and one, respectively.

It is common practice to test this

hypothesis by breaking it into two hypotheses and testing them
separately and independently, i.e. testing the hypothesis that

the

y-intercept is equal to zero, and then testing the hypothesis that
the slope is equal to one.

These tests are performed by calculating

confidence intervals (e.g. 95%) for each of the two parameters and
determining whether or not each confidence interval overlaps with
its ideal value.

For the regression line presented in Figure 7.5,

the 95% confidence interval for the y-intercept is 9.3 ± 42.7, and
that for the slope is 0.976 ± 0.049.

Both of these confidence

intervals overlap with the ideal values, and one is tempted to
conclude at this point that the ideal relationship holds, i.e. that
the results obtained with the RIA are not significantly different
from those obtained by GC-MS-SIM.
However, separate hypothesis tests for the y-intercept and
slope do not provide assurance at the given level of significance
(e.g. 95%) that conclusions for both the intercept and slope are
simultaneously correct.

In order to test the two hypotheses simul-

taneously, a joint confidence ellipse may be constructed which
incorporates all simultaneous values for y-intercept and slope
supported by the data at the chosen significance level (119, 122).
Figure 7.6 shows the 95% joint confidence ellipse for y-intercept
and slope constructed using the data presented in Figure 7.S.

The

ellipse is centered at the least squares regression estimates of the
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y-intercept and slope, shown as the point (9.3, 0.976).

The conclu-

sion that the y-intercept and slope are simultaneously not significantly different from zero and one, respectively, is supported by
the data if the point (O,l) is included within the boundaries of the
ellipse, as it is in Figure 7.6.

This suggests that that observed

deviations of the y-intercept and slope from their hypothesized
values of zero and one are likely to be due to random chance.

If

the point (0,1) had fallen outside the boundaries of the 95% joint
confidence ellipse, then it would be very unlikely that the observed
deviations of the y-intercept and slope from their ideal values were
due to random chance, and it would be concluded that either the
y-intercept or slope (or both) differs significantly from the ideal
relationship.

Note that it is possible for the values calculated

from a least squares regression analysis to pass both independent
tests while not passing the simultaneous test.

The data presented

in Figure 7.5 pass all of these.
The statistical analysis described above is based upon the
techniques of classical least squares regression.

In order for such

an analysis to be strictly valid, the data analyzed should meet
certain criteria.

First, there should be no uncertainty in the

values of the independent (X) variable, and secondly, the uncertainty in the dependent (y) variable should be constant for all values
of X (constant variance).

Unfortunately, these criteria are seldom

met in method comparison studies.

Both of the methods for measuring

adenosine concentration used in the present study incorporate
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inherent uncertainty, as shown by the error bars in Figure 7.5.

The

uncertainty in the GC-MS-SIM measurements is small compared to that
in the RIA measurements, which lends justification to the use of
GC-MS-SIM as the reference method.

However, the presence of a small

uncertainty in the reference method should not be completely ignored.

Other authors (110,111) have recommended the use of Deming's

method for determining the y-intercept and slope in regression
analyses involving errors in both X and Y.

For the data in this

study, Deming's method generates a y-intercept of 9.1 and a slope of
0.976; the close similarity between these values and those obtained
through classical least squares regression procedures suggests that
the relatively small uncertainty in the GC-MS-SIM measurements has a
negligible effect on the linear regression.
The criterion for constant variance in the Y (RIA) data is also
not met by the data in this study.

As demonstrated by the vertical

bars in Figure 7.5, the magnitude of the uncertainty in the RIA data
increases as the RIA value increases.

On the average, this uncer-

tainty is a constant percentage of the RIA value, and the Y data in
Figure 7.5 can thus be described as having a constant coefficient of
variation, defined as the standard deviation of repeated measurements of a single Y value divided by the mean of those repeated
measurements.

Although such repetitive measurements were not

performed in this study, the coefficient of variation may be estimated as one fourth of the magnitude of the RIA 95% confidence
interval for a given point divided by the RIA value of the point
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(note: the 95% confidence interval is approximately four standard
deviations).

When this calculation is performed for all of the

points in Figure 7.5 and averaged, the coefficient of variation in
the RIA data is estimated to be 0.1, or 10% of the RIA value.

Data

involving a constant coefficient of variation may be analyzed
through weighted least squares regression analysis; however,
Cornbleet and Gochman (111) have demonstrated that the classical
procedure calculates the correct regression line even with a coefficient of variation as high as 20%, so that weighted least squares
analysis is not required.

While this description of the RIA data as

incorporating a constant coefficient of variation must be regarded
as an approximation, it is a reasonable one in this case due to the
virtually parallel nature of the 95% inverse tolerance limits
associated with the logarithmic RIA standard curve (Figure 7.4).
Three major types of errors may occur between the results of
two analytical methods.
random errors.

These are constant, proportional, and

Westgard and Hunt (109) have demonstrated the

utility of statistical analysis, particularly least squares regression, in determining the nature and estimating the magnitude of such
errors in method comparison studies.

From least squares linear

regression analysis, a constant discrepancy between two methods is
reflected in the value of the y-intercept, and a proportional error
is measured as the deviation of the slope from the ideal value of
one.

Neither constant nor proportional error has been detected

between the RIA and GC-MS-SIM methods in this study, since the
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y-intercept and slope have been shown to be simultaneously not
significantly different from zero and

one~

respectively.

The major error detected statistically between these two
analytical methods is of the random type.

Random errors may be

measured from least squares regression analysis as the standard
deviation of the residual error of regression (Syx).
in Figure

7.5~

For the data

Syx is calculated to be 110 ng/ml by the classical

procedure and 108 ng/ml by Deming's procedure.

Westgard and Hunt

(109) have shown that Syx is a good estimator of random error when
the Y data have constant variance.

However~

Cornbleet and Gochman

(111) point out that when the Y data have a constant coefficient of
variation, rather than constant

variance~

increases as X and Y increase.

Thus, a more reasonable estimate of

Syx is not constant, but

the random error between these two analytical methods is the coefficient of variation, or ten percent of the RIA value.
As has been pointed out (109) statistics are not a substitute
for judgements upon the acceptability of an analytical method, but
they can provide a basis upon which judgements can be made.

The

radioimmunoassay evaluated in this study has the advantages of
simplicity, speed, and a broad range of quantitation, and is thus
well suited for use with large numbers of samples.

In contrast, the

GC-MS-SIM method is labor intensive, time consuming, and has a
restricted range of quantitation.

However, the RIA measurements

incorporate a greater uncertainty than the GC-MS-SIM measurements,
and the utility of the RIA may be limited by this uncertainty.
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Based upon the statistical analysis described in this study, the
radioimmunoassay for adenosine will be useful in experiments where a
random error of ten percent of the "true" value can be tolerated,
since neither constant nor proportional errors were detected.
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